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Abstract
Interactions between proteins regulate signaling, gene expression and many other
cellular functions. Therefore, characterizing the entire human interactome is a key
effort in current proteomics research. The existing knowledge of protein-protein in-
teractions (PPIs) is stored in a number of databases. However, PPIs have properties
that make their interpretation difficult and that are not adequately represented in a
unified way in these databases. On the one hand, the experimental reliability of the
techniques used to detect PPIs can have widely different quality with some methods
being associated with high error rates. Another problem of PPI detection meth-
ods is that many interactions are measured under artificial conditions (for example,
yeast cells are transfected with human genes in yeast two-hybrid assays) or even if
detected in a physiological context, this information is missing from the common
PPI databases.
We implement a resource that integrates human PPI data from the major expert-
curated PPI databases. To address the high uncertainty associated with experi-
mentally detected PPIs, we develop a scoring scheme that has been optimized both
computationally and by human experts to reflect the amount and quality of evi-
dence for a given PPI. To deal with the problem of missing context, we develop a
method that assigns information to PPIs inferred from various attributes of the in-
teracting proteins: gene expression, functional and disease annotations, and inferred
pathways. We demonstrate that context annotation helps to detect interactions of
higher experimental reliability and how context-filtered networks are enriched in
bona fide pathways and disease proteins. We use these context-specific networks to
identify PPIs that likely play a role in disease.
Finally, we use the integrated human PPI network for the study of the wild type
function of polyglutamine (polyQ) stretches. Expansions of these stretches have
been observed in the proteins of a large number of patients with different neurode-
generative diseases such as Huntington’s and several Ataxias. Protein aggregation,
which is a key feature of most of these diseases, is thought to be triggered by these
expanded polyQ sequences in disease-related proteins. However, polyQ tracts are
a normal feature of many human proteins, suggesting that they have an important
cellular function. To clarify the potential function of polyQ repeats in biological sys-
tems, we study the characteristics of polyQ-containing proteins in the human PPI
network. We complement the network analysis studying the repeats at nucleotide,
protein and organism level. Together, our observations suggest that polyQ tracts in
proteins stabilize protein interactions, likely through structural changes whereby the
polyQ sequence extends a neighboring coiled-coil region to facilitate its interaction
with a coiled-coil region in another protein.
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Zusammenfassung
Interaktionen zwischen Proteinen regulieren Signalwege, Genexpression and vie-
le andere zelluläre Funktionen. Die Charakterisierung der Gesamtheit menschli-
cher Proteininteraktionen gehört daher zu den wichtigsten Zielen der Proteomik.
Das existierende Wissen über Proteininteraktionen wird in Datenbanken gespei-
chert. Allerdings haben Proteininteraktionen Eigenschaften, die ihre Interpretation
und konsistente Repräsentation in Datenbanken erschweren. Zum einen besitzen
Methoden zur Detektion von Proteininteraktionen stark variierende experimentelle
Verlässlichkeit. Einige dieser Methoden sind mit sehr hohen Fehlerraten assoziiert.
Andererseits werden viele Proteininteraktionen unter artifiziellen Bedingungen ge-
messen (beispielsweise werden beim Yeast-Two-Hybrid-Verfahren Interaktionen von
menschlichen Proteinen in Hefezellen beobachtet) und selbst wenn sie unter natür-
lichen Bedingungen gemessen werden, fehlt eine Beschreibung des physiologischen
Kontexts in den gängigen Interaktionsdatenbanken.
Wir implementieren eine Anwendung, die menschliche Proteininteraktionsdaten
aus den wichtigsten, von Experten gepflegten Datenbanken integriert. Um die ho-
hen Fehlerraten von experimentell detektierten Proteininteraktionen zu adressieren,
entwickeln wir eine Funktion, die sowohl computergestützt als auch von Experten
dahingehend optimiert wird, Menge und Qualität der Evidenz einer Proteininterak-
tion zu bewerten. Um das Problem der fehlenden Kontextinformationen zu beheben,
entwickeln wir eine Methode, die Interaktionsannotationen von verschiedenen Attri-
buten der interagierenden Proteine ableitet. Dazu berücksichtigen wir gewebespezifi-
sche Expression, Funktion und Krankheitsrelevanz der Proteine sowie vorhergesagte
Signalwege, an denen die Proteine beteiligt sind. Wir zeigen, dass eine spezifische-
re Annotation einer Proteininteraktion mit höherer experimenteller Verlässlichkeit
einhergeht und dass Netzwerke, die spezifisch sind für bestimmte Kontext-Typen,
angereichert sind in kanonischen Signalwegen und krankheitsrelevanten Proteinen.
Wir benutzen die kontextspezifischen Netzwerke, um Proteininteraktionen zu iden-
tifizieren, die vermutlich eine Rolle in Krankheiten spielen.
Schließlich verwenden wir das integrierte humane Netzwerk interagierender Pro-
teine für die Untersuchung der Wildtyp-Funktion von Polyglutaminketten. Expan-
sionen dieser Ketten wurde in Patienten mit verschiedenen neurodegenerativen Er-
krankungen (wie zum Beispiel Chorea Huntington und mehreren Ataxien) beobach-
tet. Es wird angenommen, dass Proteinaggregation, ein Hauptmerkmal der meisten
dieser Krankheiten, durch die Verlängerung der Polyglutaminketten in krankheits-
relevanten Proteinen ausgelöst wird. Allerdings sind Polyglutaminketten normaler
Bestandteil vieler menschlicher Proteine, was suggeriert, dass diese Ketten eine wich-
tige zelluläre Funktion haben. Um Hinweise auf eine solche Funktion in biologischen
Systemen zu sammeln, untersuchen wir die Charakteristika von Proteinen mit Po-
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lyglutaminketten in Interaktionsnetzwerken. Diese Analyse ergänzen wir durch eine
Untersuchung der Sequenzwiederholungen auf Nukleotid-, Protein- und Organismen-
Ebene. Zusammengenommen legen unsere Beobachtungen nahe, dass Polyglutamin-
ketten Interaktionen zwischen Proteinen stabilisieren. Wahrscheinlich erfolgt diese
Stabilisierung durch Veränderungen in der Proteinstruktur, wobei die Polyglutamin-
sequenz eine benachbarte Coiled-Coil-Region erweitert, um die Interaktion mit einer
Coiled-Coil-Region in einem anderen Protein zu ermöglichen.
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1 Introduction
1.1 Motivation
Almost all cellular processes involve proteins in one way or another. Proteins bind to
each other and form complex networks of protein-protein interactions (PPI) to achieve
these functions. Accordingly, many research efforts focus on the discovery PPIs. New
experimental methods are constantly being developed to measure PPIs and the amount
of available PPI data is steadily increasing. Currently, expert-curated databases contain
tens of thousands of human PPIs.
At the same time, many experimental PPI detection techniques have high error rates
resulting in a large number of wrongly reported interactions. Additionally, most PPIs
are detected under conditions that are to a certain degree artificial, thus hindering the
interpretation of the generated data. For example, in yeast two-hybrid (Y2H), which
is currently the most frequently applied assay for the detection of direct interactions
between human proteins, the candidate proteins are expressed in yeast to monitor a
potential binding event. For non-yeast proteins, this leads to many reported interactions
that, under physiological conditions, might never occur or occur in only a very limited
number of cell types.
While for systems level analyses of the PPI network, where the focus is on global prop-
erties of the interactome (e.g., for the detection of hub proteins or frequent associations
of protein domains in interacting protein pairs) the effects of false positive interactions
might be negligible, for studies focusing on small numbers of interactions (e.g., for the
detection of causative PPIs in disease) the large number of technical and biological false
positives will hinder the generation of reliable hypotheses. In general, the development of
methods and tools to identify and specifically analyze PPIs of higher technical reliability
and biological relevance lags behind the rate by which new PPI data is generated.
In this work, we first present a method to identify interactions supported by more reli-
able experimental evidence and then assign biological context information to PPIs. This
allows us to generate context-specific, high-confidence PPI networks. We will illustrate
the usefulness of this approach by demonstrating how the resulting networks allow one
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to highlight pathway information or disease-relevant interactions.
1.2 Overview
Chapter 2 starts with an overview of the biology of proteins and their interactions. It
introduces basic concepts related to the generation and analysis of PPI networks both
from an experimental and a computational point of view. Advantages and disadvantages
of the most commonly applied experimental techniques to measure PPIs are discussed.
The major projects that collect and provide experimentally generated PPI data are
introduced. The basics of graph theory and common PPI network analysis tasks are
explained. The chapter closes with a discussion of the relevance of PPIs for disease.
Chapter 3 addresses the problem of high uncertainty in PPI networks by defining a
scoring scheme for published PPIs that reflects the amount of evidence supporting each
interaction. This scoring method is implemented as a web tool providing a resource that
automatically retrieves the newest interactions from expert-curated databases, integrates
them into a single database and scores them according to our method. We will also
discuss problems associated with the integration of multiple PPI networks: both research
interests and technical limitations bias most networks that are currently being reported.
We will quantify the extent to which this affects large integrated networks such as ours.
After developing a method to select reliable interactions, in Chapter 4 we present
a strategy to detect interactions that are relevant to a specific problem by annotat-
ing interactions with context information (e.g., from expression profiles or functional
information of the participating proteins). We illustrate how the annotation with con-
text information in combination with network algorithms is able to select interactions
of high biological relevance. We then use our method to detect interactions that play
a role in the crosstalk between influenza proteins with innate immune response and
phosphorylation-dependent PPIs related to Alzheimer’s disease.
In Chapter 5 we address an open biological question that has been discussed for many
years in the scientific community: whether there is a wild-type function of polyglutamine
(polyQ). By providing evidence that polyQ-containing proteins underlie evolutionary se-
lection and illustrating that polyQ proteins have distinctive features in the PPI networks
of several species, we develop the hypothesis that polyQ has a specific function in medi-
ating PPIs.
2
2 Protein-protein interactions
2.1 Cellular function emerges from the interaction between
proteins
Proteins are among the most important molecules in living organisms and achieve many
cellular functions. As indicated by the protein database UniProt (Apweiler et al., 2011),
more than 20,000 human proteins with diverse biological roles are known: approximately
10% are involved in binding of the DNA to control gene expression, 7% are receptors,
which sense and report the presence of ligands, and 3% are kinases, which catalyze the
transfer of a phosphate group (usually from the coenzyme ATP) to a substrate.
Proteins are composed of combinations of 20 different amino acids each of which has
different biochemical properties (such as charge, hydrophobicity and polarity), which
determine the protein’s structure and function. Proteins usually do not act alone but
carry out their function in cooperation with other proteins. When this cooperation
involves a specific physical binding event between the participating proteins it is termed
a PPI. Here, we use the term PPI to distinguish from a mere functional relation where
both proteins are involved in the same cellular function but not necessarily physically
interact or from a genetic interaction where mutations in two or more genes lead to
the same phenotype. In the following, interaction (or interactome for the sum of all
interactions in an organism) refers to PPI unless otherwise stated.
Many cellular functions are achieved by the complex interplay between proteins. To
name a few examples:
• PPIs mediate the transduction of signals from the outside to the inside of a cell
where a physiological response happens. The external signals are sensed by recep-
tor proteins, which often control the activity of intracellular kinases. The kinases
in turn propagate the signal and modify the activity of target proteins. These
cascades of PPI events are termed signaling pathways.
• The transcriptional machinery, which controls gene expression, consists of large
protein complexes, which dynamically assemble in the nucleus of the cell.
3
2 Protein-protein interactions
Figure 2.1: Increase of human PPIs stored in the manually curated PPI
databases BioGRID and search results in PubMed for ’protein-protein inter-
action’ per year.
• Structural components of the cell rely on PPIs: Actin assembles into microfila-
ments, which form part of the cytoskeleton. The motor protein myosin realizes
muscle fiber contraction by moving along such actin filaments.
All of these functions require the highly specific recognition of protein interaction part-
ners. Furthermore, these protein binding events underlie delicate control mechanisms
and are dependent on the type and state of the cell in which they occur.
Accordingly, only a small fraction of all possible combinations of protein pairs interact.
Estimates of the size of the human interactome range from around 130,000 to 260,000
interactions (Hart et al., 2006; Venkatesan et al., 2009). Over the last years, the amount
of PPI data increased steadily (see Figure 2.1). Even though the cumulative amount
of reported interactions approaches the estimated lower limit of the human interactome
size, due to the high error rates of the experimental techniques, the majority of PPIs
likely remain to be discovered.
Knowledge of PPIs is crucial for the understanding of protein and cellular function.
Therefore, completing the characterization of the human interactome is a key effort in
proteomics. Many experimental methods exist to detect interactions and algorithms
have been developed to interpret the generated PPI network data.
4
2 Protein-protein interactions
Figure 2.2: Basic principles of two commonly applied methods for the detec-
tion of PPIs. (A) Y2H detects direct physical binding events between a bait and a
prey protein while (B) TAP/MS reports the composition of complexes in which the bait
protein is found.
2.2 Detection methods
PPIs can be measured by many experimental methodologies, which have hugely different
experimental set-ups and degrees of confidence. They either detect a direct physical
binding event between two proteins (binary methods) or isolate a complex whose protein
composition is subsequently determined (co-complex methods). The protein (or group
of proteins) whose interaction partners are to be determined is termed the bait protein.
The potential interaction partners are called prey proteins.
The most commonly applied method for detecting binary PPIs is Y2H, which was
first applied in the late 1980s (Fields and Song, 1989). It is a genetic high-throughput
method that is based on the fact that some eukaryotic transcription factors, such as
the yeast transcriptional activator GAL4, are composed of two subunits, which need to
assemble for the regulation of transcription. GAL4 consists of a DNA-binding domain
(BD) and an activation domain (AD). To detect the interaction between a bait and a
prey protein, the bait is fused to the BD and the prey to the AD. The fusion constructs
are expressed in the same yeast cell, which contains a reporter gene that is activated
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by a GAL4 responsive promoter. Neither of the two GAL4 subunits alone is sufficient
to drive the expression of the reporter gene. Only if the bait and prey protein interact
and, in doing so, bring the BD and the AD into close proximity a functional activator
is formed and the expression of the reporter gene driven (Figure 2.2A).
Y2H can be automated up to genome-wide scale by expressing bait and prey proteins
in haploid yeast strains of opposite mating type. The yeast strains are combined and
the resulting diploid yeast clones coexpress the combination of bait and prey proteins.
As a result, large amounts of proteins can be screened for interactions at the same time
at relatively low costs. Another advantage of Y2H is its sensitivity towards transient
interactions since the reporter gene expression significantly amplifies the signal (Estojak
et al., 1995). A general drawback of Y2H is that it detects interactions outside their
normal environment (e.g., in case of non-yeast proteins or even yeast proteins if they are
cytoplasmic). As a consequence, proteins might not undergo correct post-translational
modifications (PTMs) and folding. Also, multiple studies estimated high false-positive
rates for Y2H (Hart et al., 2006; Mrowka et al., 2001; Von Mering et al., 2002). Usually,
error rates are deduced from the overlap between the PPI networks generated in different
studies. Venkatesan et al. (2009), in contrast, explained the low overlap between different
studies with a low sensitivity (by missing many interactions) rather than with a lack of
specificity.
In several seminal studies Y2H has been applied to generate draft PPI maps of entire
organisms: Saccharomyces cerevisiae (Ito et al., 2001; Uetz et al., 2000), Drosophila
melanogaster (Formstecher et al., 2005) and human (Rual et al., 2005; Stelzl et al., 2005).
Additionally, disease networks (Kaltenbach et al., 2007; Lim et al., 2006) and functional
subnetworks (Bandyopadhyay et al., 2010; Colland et al., 2004; Lehner and Sanderson,
2004) have been elucidated using large-scale Y2H approaches. As of today, around 31%
of all interactions in human PPI databases were measured with Y2H (Schaefer et al.,
2012a) placing this method number one among the most frequently applied PPI detection
techniques in humans.
Another method for the detection of direct physical PPIs is luminescence-based mam-
malian interactome mapping (LUMIER) (Barrios-Rodiles et al., 2005): a bait protein is
fused to luciferase, an enzyme that catalyzes a light-emitting reaction. Another protein
is fused to a FLAG-tag, which allows one to capture the tagged protein. An interaction
can be detected by a luminescence signal. An obvious advantage of LUMIER is that it
allows the study of mammalian PPIs in mammalian cell types.
LUMIER was used to identify the components of the TGF-β (Barrios-Rodiles et al.,
2005) and the Wnt (Miller et al., 2009) signaling pathways. The method was also used
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to validate PPIs previously measured with Y2H (Braun et al., 2008).
In contrast to the previously described binary approaches, co-complex methods re-
quire an initial purification step in which the protein complex is isolated. The complex
composition is then characterized, e.g., using mass spectrometry (MS) where the protein
identity of complex members is revealed by measuring the characteristic mass-to-charge
ratio of charged peptides. For complex purification, the bait protein is either directly
targeted with an antibody (co-immunoprecipitation) or fused to a tag, which is then
captured rather than the bait protein itself. Tandem affinity purification (TAP) (Puig
et al., 2001; Rigaut et al., 1999) is a more stringent purification strategy in which two
sequential affinity tags are fused to the bait protein (Figure 2.2B). The two successive
purification steps decrease the number of non-specific binding partners but may also
remove weak or transient interaction partners of the bait protein (Von Mering et al.,
2002).
Several large scale studies identified protein complexes in yeast (Gavin et al., 2002,
2006; Krogan et al., 2006) and Escherichia Coli (Butland et al., 2005) using TAP/MS.
In human cell lines, TAP/MS was used to identify complexes involved in specific path-
ways (Bouwmeester et al., 2004; Major et al., 2007) and in the transcription machinery
(Jeronimo et al., 2007).
Another MS-based method that aims to overcome the problem of missing weak in-
teractions while removing contaminants is quantitative proteomics. Here, the relative
abundance of interaction partners of a tagged protein in comparison to a control exper-
iment (e.g., the tag alone or RNAi knockdown of the target protein) is determined. A
recently developed variant of quantitative proteomics is stable isotope labeling by amino
acids in cell culture (SILAC) (Mann, 2006) in which two populations of cells (one ex-
pressing the tagged bait protein and the other expressing the control) are grown: one
in light and one with heavy amino acid medium (most commonly different isotopes of
arginine or lysine). This differential labeling leads to a mass shift of the proteins of the
cell that can be detected by MS and allows to determine the required abundances (Ver-
meulen and Selbach, 2009). The stringent purification in TAP/MS and the quantitative
approach correcting for unspecific binding in SILAC are commonly believed to increase
the specificity of PPI detection importantly.
Large scale interaction maps among kinases (Oppermann et al., 2009) and proteins
involved in the cell cycle (Olsen et al., 2010) have been generated using SILAC in human
cell lines. Differences in the relative abundance ratios were exploited to distinguish
between stable and transient interactions (Wang and Huang, 2008).
In addition to experimental methods, computational methods have been developed
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that predict protein interactions based, for example, on orthology, protein sequence, do-
main composition, co-expression and functional annotations. Sometimes, combinations
of these features are applied to predict novel interactions or to estimate the reliability of
experimentally measured PPIs (Brown and Jurisica, 2005; Jensen et al., 2009). In sev-
eral species, similarity in the Gene Ontology (GO) term description of the protein pair
and coexpression over many conditions or tissues have been shown to be good predictors
of interactions (Lu et al., 2005; Maetschke et al., 2012; Qi et al., 2006). Sequence and
the presence of potentially interacting domains generally perform worse (Ta and Holm,
2009; Yu et al., 2010). Recently, physical docking methods were shown to produce good
results in the prediction of PPIs (Wass et al., 2011). This method, however, is limited
by the computational complexity and the large number of proteins for which the tertiary
structure has not yet been resolved.
Different decisions on the study design introduce technical and selection biases, which
lead to an enrichment of certain protein classes and pathways in the measured PPI
networks (Futschik et al., 2007; Von Mering et al., 2002):
1. TAP/MS has a high sensitivity towards abundant proteins. As a consequence,
interactions between highly abundant proteins are more easily detected (Björklund
et al., 2008; Ivanic et al., 2009; Von Mering et al., 2002).
2. Due to physiochemical constraints, different experimental methods preferentially
detect interactions within subsets of proteins with certain properties. For example,
Y2H tends to detect interactions between protein pairs located in the nucleus
(Jensen and Bork, 2008) and TAP/MS reports with a higher frequency interactions
involving small proteins under 15 kDa (Gavin et al., 2002).
3. Some proteins are more frequently studied than others. This selection bias is par-
ticularly strong for literature-curated (for example, Peri et al. (2003) preferentially
consider disease-related genes for their expert-curated PPI database HPRD) and
integrated networks (in Chapter 3 we will demonstrate that proteins are studied
with largely different frequencies and how this affects integrated PPI databases).
2.3 Curation and availability
Experimentally detected PPIs are collected in several publicly available databases that
are curated by experts and make the PPI’s supporting evidence easily accessible. Usually,
these databases provide meta-data such as the study in which the interaction has been
described and which techniques have been applied to measure the interaction. They
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Figure 2.3: Agreement between the three largest publicly available expert-
curated PPI databases HPRD, BioGRID and IntAct. Only human PPIs are
considered.
implement different mechanisms to query and display the data. These databases include
BioGRID (Stark et al., 2011), HPRD (Keshava Prasad et al., 2009), IntAct (Aranda
et al., 2010) and MINT (Ceol et al., 2010).
As it has been previously noted, many of the interactions are unique to a certain
database (Futschik et al., 2007; Lopes et al., 2011) and few interactions are listed in
all of them. Figure 2.3 illustrates the current overlap for the three largest expert-
curated databases. Accordingly, several databases integrate the data from multiple
expert-curated resources: UniHI (Chaurasia et al., 2007) and iRefWeb (Turner et al.,
2010) are comprehensive PPI resources integrating the major public PPI databases. The
popular functional interaction resource STRING (Szklarczyk et al., 2011) additionally
incorporates interactions computationally predicted by various methods.
To assess the quality of PPI data stored in public databases, Cusick et al. (2008)
re-evaluated randomly selected PPIs from several manually curated resources. They
found that both in human and yeast more than a third of the probed interactions were
wrongly annotated, with the most frequent errors being wrongly assigned species, in-
correctly reported protein identity and absence of adequate experimental settings. On
top of experimental noise, these wrongly curated interactions add another layer of error.
Despite the high reported error rates, expert-curated PPI databases are often used as
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gold-standard datasets for various purposes such as estimating performance parameters
of a screen (Bandyopadhyay et al., 2010) or training of classifiers for the prediction of
PPIs (Geisler-Lee et al., 2007).
Von Mering et al. (2002) reported a higher accuracy for PPIs supported by multi-
ple studies. Similarly, Cusick et al. (2008) found fewer wrongly annotated interactions
among PPIs reported in several databases. Both observations open the possibility for
evidence-based selection of likely true PPIs from the entire set of reported interactions.
However, assigning scores that estimate the experimental reliability based on the cu-
mulative evidence supporting the interaction remains challenging (Braun et al., 2008).
Accordingly, only few manually curated databases associate reliability scores with PPIs.
An exception is the database MINT, which scores interactions detected in small scale
experiments higher than those from high-throughput experimental methods, considers
the number of studies in which the interaction has been found and rates conservation
of the interaction between homologous proteins (Ceol et al., 2010). IntAct recently an-
nounced that it will also release an evidence-based confidence score soon (Kerrien et al.,
2012).
An important step for allowing comparability between different studies, work groups
and databases has been the standardization attempts of the Human Proteome Orga-
nization Proteomics Standards Initiative (HUPO-PSI). They released the Proteomics
Standards Initiative Molecular Interaction (PSI-MI) standard, which defines the repre-
sentation of molecular interaction data and, by defining a controlled vocabulary, their
annotation with information on the experiments conducted to measure the interaction
(Hermjakob et al., 2004). Additionally, a PPI exchange standard has been developed:
Proteomics Standards Initiative Common Query Interface (PSICQUIC) (Aranda et al.,
2011). PSICQUIC specifies a protocol (accessible by the web services SOAP and REST)
that standardizes access to several of the major PPI databases and enables automated
data retrieval from multiple sources.
Due to the large number of interactions available in PPI databases, tools are required
to display and layout the network data. A popular graph viewer for PPI networks
is Cytoscape (Shannon et al., 2003). It allows one to render even large networks of
thousands of interactions. It implements various layout algorithms, offers a basic network
analysis utility and can be extended by a large number of plugins implementing all kinds
of functionality ranging from interfaces to the aforementioned PPI databases to high-
level network algorithms (examples will be given in the next section).
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Figure 2.4: Topological properties used to characterize and identify essential
components of PPI networks.
2.4 Network analysis
Various research questions related to the function of single or groups of interacting
proteins can be addressed with the help of PPI networks. Therefore, physical interactions
between proteins in a network are modeled in the formal framework of graph theory. A
graph G = {V,E} consists of a set of nodes V and a set of edges E that connect the
nodes. Topological measures allow the characterization of the properties of the graph
and network algorithms allow the identification of important components of the graph
(Figure 2.4). When modeling PPIs, the nodes of a graph represent proteins and edges
indicate interactions between proteins.
In graph theory directions can be assigned to edges. With respect to PPI networks,
directed edges are commonly used to model signal flow between proteins.
Several studies showed that the structure of PPI networks is not random. Locally,
network motifs are topological patterns of nodes and edges that appear more often than
expected by chance. They constitute building blocks of the global network architec-
ture and often fulfill biological functions in cell signaling pathways such as feedback or
feedforward loops (Milo et al., 2002).
The degree k of a node indicates how many edges connect the node with other nodes
in the network. The degree distribution P (k) gives the probability for a node to have
k edges. Degree distributions of natural networks, such as PPI networks, have been
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reported to follow a power-law degree distribution (P (k) ∝ k−γ where γ is a constant)
(Barabási and Albert, 1999; Yook et al., 2004) with many nodes forming few connections
and a small number of nodes connecting a large number of other nodes. These highly
connected nodes are termed hubs. Networks having this degree distribution are called
scale-free. An important consequence is the small world property of PPI networks. It
results in short average number of edges separating pairs of proteins.
Studies in yeast reported that hub proteins fulfill important cellular functions. Jeong
et al. (2001) observed a higher number of proteins essential for growth among hub
proteins. Yu et al. (2008) challenged these findings and attributed these observations
to the experimental design of the initial yeast PPI screens with a higher number of
essential proteins in the bait libraries (in other words, the aforementioned selection bias
shapes the topology of measured PPI networks). They, in contrast, relate hub proteins
to pleiotropy, a higher phenotypic diversity upon gene knock-out. Analogously, there is
a debate as to whether hub proteins are more frequently among essential and disease-
related proteins in humans. Proteins involved in cancer have been observed to have a
higher number of PPIs (Jonsson and Bates, 2006; Wachi et al., 2005). On the other
hand, Goh et al. (2007) found that the majority of disease proteins have no elevated
level of interactions but essential proteins (whose orthologs in mouse lead to embryonic
or postnatal lethality upon deletion) do have higher number of reported interaction
partners. Again, the selection bias effect on these conclusions is difficult to estimate.
Another topological property of PPI networks is their modular organization (Barabási
and Oltvai, 2004; Hartwell et al., 1999; Ravasz et al., 2002; Rives and Galitski, 2003).
Modularity quantifies the strength of the network division into densely interacting groups
of proteins. A measure to describe the density of a module is the clustering coefficient.
It indicates for a node i the fraction of all possible edges realized among its interaction
partners:
Ci =
2ei
ki(ki − 1)
with ki indicating the number of interaction partners of node i and ei the number of
edges among these neighbors.
Network modules suggest that the participating proteins act closely together such as
in protein complexes or cellular pathways. Accordingly, several approaches exploit the
modular organization of large PPI networks to predict proteins that act together in func-
tional subnetworks. Various network clustering tools allow the identification of groups
of closely interacting proteins. Popular implementations are ClusterONE (Nepusz et al.,
2012) and the Cytoscape plugin MCODE (Bader and Hogue, 2003). Usually, a large
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network is scanned for modules with high clustering coefficients and more interactions
formed within the module than to proteins outside the module. A maximum coefficient
is achieved within a clique, which is a fully connected graph neighborhood. A graph clus-
tering algorithm that is able to efficiently detect these structures is CFinder (Adamcsek
et al., 2006).
Other studies select sets of proteins based on a certain phenotype and construct max-
imally parsimonious subnetworks that link these proteins (Calvano et al., 2005; Chuang
et al., 2007; Said et al., 2004; Scott et al., 2005; Yosef et al., 2009). If two indepen-
dent sets of proteins (e.g., membrane-bound receptors and transcription factors that
respond to these receptors) are defined, edge directionality can be inferred assuming
that the shortest paths between the sets represent information flow within the network
(Vinayagam et al., 2011). The start nodes on these paths (i.e., the receptors) are called
sources and the end nodes (i.e., the transcription factors) sinks.
A common analysis involving PPI networks is to infer the unknown function of a pro-
tein based on the known functions of its interaction partners. The underlying assumption
is the guilt-by-association principle, which states that two proteins that interact likely
share a common function (Oliver, 2000). This principle underlies many protein anno-
tation tools. See for example the popular gene function prediction tool geneMANIA
implemented as a web server (Warde-Farley et al., 2010) and a Cytoscape plugin (Mon-
tojo et al., 2010).
Network-level investigations have revealed intriguing topological features of disease
proteins: Lim et al. (2006) showed that different ataxia disease proteins share many
interaction partners. Chen et al. (2006) found Alzheimer’s disease proteins more closely
located to each other in the global human PPI network than expected by chance. Gandhi
et al. (2006) extended this observation to other diseases. This illustrates that disease
proteins are likely to interact with proteins causing the same or a similar disease. Ac-
cordingly, a variety of approaches exists that seek to predict disease proteins based on
their proximity or co-clustering with known disease factors (reviewed in Barabási et al.
(2011)).
Most PPI detection methods do not reveal which parts of the proteins that have been
measured to interact with each other mediate the binding. The definition of protein do-
mains and their functions (including the function of providing a binding surface for other
proteins) is an important step in understanding the cellular role of proteins. Therefore,
several studies aim to predict which domains mediate the binding from large sets of
PPIs. These approaches usually assume that these domain pairs co-occur more often
in pairs of interacting proteins than expected by chance (Deng et al., 2002; Guimarães
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et al., 2006; Nye et al., 2005; Riley et al., 2005; Wang et al., 2007).
2.5 Alterations of the protein-protein interaction network in
disease
As the function of a cell is a dynamic property of the cooperation between many proteins,
diseases can often be attributed to the interruption of normally occurring PPIs or to the
formation of novel PPIs that would not occur in a healthy cell. Consequently, research
expands its focus from locating disease mutations towards a systems level understanding
of how mutations can alter the function of a protein and the implications for its binding
behavior. For several diseases it has been shown that changes in the PPI patterns of
the disease-causing proteins contribute to disease progression (Chiti and Dobson, 2006;
Giorgini and Muchowski, 2005; Ross et al., 2005; Shy et al., 2004).
An example of a broad class of diseases that is characterized by the impairment of
the natural balance of the interactome are neurodegenerative diseases. These include
the polyQ disorders Huntington’s disease (HD) and several ataxias (Gatchel and Zoghbi,
2005). The polyQ diseases are characterized by the length expansion of a polyQ stretch
over a critical length threshold. There are 86 human proteins with a polyQ stretch
consisting of at least 10 glutamines in a row (allowing for one mismatch; see Chapter 5).
9 of them are known to cause neurodegenerative diseases when the polyQ stretch gets
expanded over a protein-specific length threshold (Gatchel and Zoghbi, 2005). For HD
the critical length is reached when the polyQ stretch in the protein huntingtin (having
a wild type length of 11 to 34 residues) is expanded to over 40 glutamines.
Even though the pathomechanism of polyQ diseases remains poorly understood, the
formation of insoluble protein aggregates is a key feature of all known polyQ diseases
(Kopito, 2000; Ross, 1997; Tran and Miller, 1999). Biochemical and cell biological exper-
iments have demonstrated that expanded polyQ tracts drive the spontaneous assembly of
insoluble protein aggregates in disease model systems (Warrick et al., 1998), suggesting
that polyQ-mediated protein misfolding and aggregation are critical for disease develop-
ment. However, it remains unclear whether polyQ-mediated aggregation of proteins is
the cause or the consequence of progressive neurodegeneration in polyQ diseases (Chai
et al., 2002; Kuemmerle et al., 1999).
Many observed effects support the idea that the alteration of normal PPI patterns is
critical for polyQ disease development:
• Interaction partners of the wild type protein are found in pathological aggregates.
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For example, Chai et al. (2001) showed that aggregates formed by Ataxin-3 with
expanded polyQ contain several of the wild type Ataxin-3 interaction partners.
• Many proteins found in polyQ-mediated aggregates fulfill important cellular func-
tions. Components of the ubiquitin-proteasome system, heat shock proteins, and
transcription factors have been identified (Boutell et al., 1999; Cummings et al.,
1998; Mitsui et al., 2002; Nucifora et al., 2001; Suhr et al., 2001b). This supports
the idea that by the recruitment of essential proteins into the aggregates important
cellular processes might be blocked.
• For several interactions between a polyQ-containing and another protein an in-
crease or decrease of the interaction strength in dependence of the polyQ length
has been described, as reviewed in Li and Li (2004).
Together these observations suggest that an interplay between the loss of naturally oc-
curring PPIs, increase of interaction propensity for wild type interaction partners as well
as aberrant PPIs with the mutated protein contribute to disease progression.
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3.1 Motivation
Published PPIs are collected and stored in several expert curated databases. Neverthe-
less, the overlap between these databases is small (Futschik et al., 2007; Lopes et al.,
2011) and many reported interactions are likely false-positive observations. Few re-
sources exist that integrate PPI data with experimental meta-data and allow users to
filter out interactions that are supported only by poor experimental evidence.
The computational use of PPI datasets often requires selecting a maximum number
of PPIs at a particular level of confidence. For example, the quality of a novel PPI
dataset may be evaluated by its overlap with known, highly reliable interactions, whereas
a statistical analysis (such as predicting domain-domain interactions from PPI data)
might require a large number of interactions therefore benefiting from a less restricted
set of PPIs. The flexible selection of PPI datasets at various confidence levels requires
a continuous scoring scheme for PPIs reflecting the reliability of their experimental
characterization.
With the objective of creating a resource containing a maximum number of interactions
and allowing the selection of PPIs by experimental confidence cut-offs, we generated
HIPPIE (Human Integrated Protein-Protein Interaction rEference), a scored human
PPI collection integrated from multiple sources. We associated confidence values to each
interaction that reflect the amount and quality of evidence supporting the interaction
combining three types of information: experimental techniques used, number of studies
describing the PPI, and reproducibility in model organisms. HIPPIE’s scoring scheme
has been optimized by human experts as well as a computer algorithm. We show that
these scores correlate to the quality of the experimental characterization.
To provide a convenient tool for doing network analyses focused on likely true PPI
sets by generating subnetworks around proteins of interest at a specified confidence
level, we implemented a web tool together with a fully automated update routine that
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regularly retrieves novel interactions from the major PPI resources and integrates them
to HIPPIE.
Obviously, the selection of proteins that are selected for PPI assays is not random:
Some bait and prey libraries covering a subset of the proteome are frequently used and
research focuses on specific proteins, pathways or diseases. We aim to quantify the
resulting bias in the integrated PPI resource HIPPIE caused by the non-uniform usage
of bait proteins and describe its impact on the network topology.
3.2 Evidence-based scoring of protein-protein interactions
Expert-curated databases provide PPI data annotated with meta-information about
the experiments conducted to measure the PPI. These curation efforts are increasingly
standardized (see section 2.3), which allows the automated extraction and processing
of relevant information. Our goal was to merge the major publicly available PPI data
repositories to maximize the coverage of the human PPIs experimentally detected so
far, while using the meta-information to associate each interaction with a confidence
score reflecting the amount and quality of evidence supporting the interaction. While
merging the different data sources we extracted information about which experimental
system was used to detect each interaction and whether there were several studies in
which the interaction was described. Additionally we retrieved the interaction data from
PPI databases that link interactions in non-human model organisms to their human
orthologs. From these different types of information (experimental systems, number of
studies and reproducibility in other organisms) we calculated an overall score reflecting
the reliability of each interaction.
3.2.1 Integration of human protein-protein interaction data
We retrieved and integrated all data stored in the major PPI databases listed in Table 3.1.
From BioGRID we removed genetic interactions, which are generated by methods that do
not require a direct physical contact of the associated proteins. We extracted binary PPI
information together with annotation data required for the confidence score calculation
from these resources. Additionally, we extracted the information describing whether an
interaction was a direct physical interaction or whether the proteins were just identified
as members of the same complex.
We identified studies that were not covered by the source databases and integrated
them as well (Albers et al., 2005; Bell et al., 2009; Colland et al., 2004; Goehler et al.,
2004; Kaltenbach et al., 2007; Lehner and Sanderson, 2004; Lim et al., 2006; Nakayama
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Database Size Format PSICQUIC Reference
HPRD 38627 self defined no Keshava Prasad et al. (2009)
BioGRID 28514 PSI-MI yes Stark et al. (2011)
IntAct 26716 PSI-MI yes Aranda et al. (2010)
MINT 14739 PSI-MI yes Ceol et al. (2010)
BIND 1532 PSI-MI yes Bader et al. (2003)
DIP 1504 PSI-MI yes Salwinski et al. (2004)
MIPS 250 PSI-MI no Pagel et al. (2005)
Table 3.1: Access and curation characteristics of PPI databases integrated
in the first publicly released version of HIPPIE (v1.2). The size column lists
the amount of human PPIs and the PSICQUIC column indicates if the database can be
programmatically accessed via PSICQUIC.
et al., 2002; Rual et al., 2005; Stelzl et al., 2005; Venkatesan et al., 2009). For these
interaction sets we manually filled in the missing annotation information. For the first
public version of our integrated PPI resource (HIPPIE v1.2; November 2011) we assem-
bled 72,916 interactions from which more than 99% were associated with experimental
information. Due to bi-annual updates, the number of interactions stored in HIPPIE is
constantly growing. As of August 2012, HIPPIE contains 109,670 PPIs.
For confidence scoring purposes, we also retrieved data from three databases that map
interactions between non-human protein pairs to their human orthologs: HomoMINT
(Persico et al., 2005), I2D (Brown and Jurisica, 2005) and the PPI dataset from Lehner
and Fraser (2004).
A main challenge when integrating different public PPI databases and datasets is
the different use of gene or protein identifiers. We aimed at mapping all protein pairs
collected in HIPPIE to Entrez Gene and UniProt identifiers. For this purpose we applied
the database identifier mapping tables curated by UniProt (Apweiler et al., 2011) and
the HUGO Gene Nomenclature Committee (Seal et al., 2011). We mapped all database
entries to their canonical representatives and did not consider splicing forms.
3.2.2 Score calculation
We calculated a score S between 0 and 1 for each interaction reflecting the reliability
of its combined experimental evidence. This score was calculated as a weighted sum
of three different subscores which are ss (a function of the number of studies in which
an interaction was detected), st (a function of the number and quality of experimental
techniques used to measure an interaction; see below for details) and so (a function of
the number of non-human organisms in which an interaction was reproduced). Each
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of these three subscores si were calculated with a non-linear saturating function of the
form:
si(n) =
2
1 + e−ai∗n − 1
such that si(0) = 0 and si(∞) = 1, where the ai are constants that control the steepness
of the function.
For subscore ss, n is the number of different studies where the interaction was reported
(number of PubMed identifiers associated), regardless of whether multiple experimental
evidence was provided in each study.
For subscore so, n is the number of species where orthologs of the interacting pro-
teins could be defined and were found experimentally to interact (currently Bos taurus,
Caenorhabditis elegans, Canis familiaris, Drosophila melanogaster, Gallus gallus, Mus
musculus, Rattus norvegicus, Saccharomyces cerevisiae, and Sus scrofa).
For subscore st, n is a sum of scores from different experimental techniques by which
an interaction was verified (even if used in the same study). Most PPI databases use
controlled vocabulary descriptors for these experimental techniques as defined by the
PSI-MI ontology (Hermjakob et al., 2004), however for some terms we could not find
an equivalent ontology term. Manual curation was used to assign a score to each PPI
detection method ranging from 0 (no experiment assigned, less than 1% of PPIs) to 10.
Scores and corresponding PSI-MI codes are displayed in the Appendix, Table 1. Methods
that can ascertain interactions with the highest reliability, such as in vitro techniques
like X-ray crystallography, were assigned the highest scores. Complementation-based
assays and affinity based technologies were roughly equally scored with an average value
of 5, slightly increased for those methods that are generally used in homologous, more
physiological setups, such as Fluorescence Resonance Energy Transfer (FRET). Method-
ologies that do not directly provide evidence for interaction, such as colocalization or
cosedimentation, are scored with the lowest values.
The total score S was calculated as a weighted sum of the three subscores:
S = wsss + woso + wtst
with ws + wo + wt = 1.
It is important to note that our dataset includes only interactions that were exper-
imentally verified with human proteins: no interaction received a score alone from its
verification in non-human organisms. We also note that this scoring scheme does not
consider computational evidence other than the definition of orthology relations from
human proteins to proteins in other organisms.
19
3 High-confidence protein-protein interactions
3.2.3 Parameter selection
The six free parameters of the scoring formula (as, ao, at, ws, wo and wt) were optimized
by performing a grid search in the parameter space. We performed the search in the
range [0, 3] for the ai and in the range [0, 1] for the wi. We chose a step width of 0.1
for both ai and the wi. The step width was chosen sufficiently small such that selecting
neighboring parameter combinations resulted only in small changes in the interaction
scores, which decreased the probability of missing an optimal solution. Constraints were
set on the weights wi by requiring that they sum up to 1.
PPIs are sometimes reported in multiple studies. We reasoned that we could use
this property to assess the performance of a parameter combination. To perform this
evaluation we used the IntAct dataset (version from August 2011) consisting of 28,073
interactions (38.5% of HIPPIE). This dataset has explicit associations between studies
and experiments, and the experimental information is annotated following the PSI-MI
format.
The assessment of performance of a parameter set was done by successively removing
each one of the 109 studies in IntAct that contain at least 10 interactions and more than
2 PPIs found in multiple studies. For each study j, we recalculated the scores of the
remaining dataset, IntActred, found the set of PPIs described both in the study j and in
IntActred, {IntActred
⋂
studyj}, and computed the deviation from random expectation
of the number of highly scored interactions within the overlap:
devj =
|scores(IntActred
⋂
studyj) > Q3|
|IntActred
⋂
studyj |
0.25
where Q3 is the upper quartile of the score distribution of IntActred.
To measure the overall performance of a parameter combination we chose a function f
of the weighted mean of the logarithm of devi over all studies:
f =
∑
j vj ∗ log2 devj
n
where the weights vj were chosen proportional to the overlap size between IntActred and
studyj and n is the number of studies.
We found several optimal parameter combinations (several thousand optimal combi-
nations out of more than 700,000 different parameter combinations tested) maximizing
the function f (with max(f) = 1.023). From the equally well performing parameter
combinations we chose the set of parameters that resulted in the largest spread of the
distribution of scored interactions. For that purpose the scores of the entire HIPPIE
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database were repeatedly calculated for each of the optimal parameter combinations
and for each score distribution the interquartile range (iqr) was determined. We found
that the parameter set [as = 2.3, ao = 1.6, at = 0.2, ws = 0.6, wo = 0.1, wt = 0.3] max-
imized both f and iqr. The optimal selection of parameters weights the reproducibility
in independent studies higher than the amount and quality of experimental techniques
applied and the conservation of the interaction between orthologous protein pairs.
3.2.4 Evaluation
The number of PPIs derived using different experimental system types was highly vari-
able. HIPPIE integrates various datasets dealing with different experimental systems and
thus contains a larger amount of interactions than each of those sets separately. Values
for three commonly applied techniques to detect PPIs: Y2H, anti-bait coimmunoprecip-
itation (Coprep), and TAP are shown in Figure 3.1, which together cover 78% of the
total amount of proteins in the version v1.2 of HIPPIE, but only around 50% of its in-
teractions. Coprep and TAP share relatively many PPIs between each other (139 PPIs)
compared to the other pairwise overlaps between methods. For example, TAP shares 95
interactions with Y2H despite the much higher amount of Y2H interactions as compared
to Coprep. This higher overlap between Coprep and TAP in comparison with the Y2H
data might reflect the similarity between the first two approaches in comparison with
the latter, as Coprep and TAP are both based on antibody capture of a protein complex
while Y2H is based on the reconstitution of a binary interaction inside of a heterologous
system (yeast).
To illustrate the benefit of using a large dataset such as HIPPIE, we compared it
with novel high-throughput PPI datasets not used for its production. We chose three
high-throughput PPI datasets from the recent literature: two Y2H datasets, Y2He1
(Bandyopadhyay et al., 2010), containing 551 PPIs between 434 proteins, and Y2He2
(Wang et al., 2011), containing 3484 interactions between 2582 proteins, and a MS
dataset, MSe (Behrends et al., 2010), containing 711 PPIs between 424 proteins. The
coverage of the Y2He1, Y2He2 and MSe datasets by HIPPIE was of 120 (21.8%), 296
(8.5%) and 73 (10.3%) PPIs, respectively.
We evaluated the usefulness of the HIPPIE score using the three novel datasets. The
HIPPIE database was divided in a high quality subset containing the top 5% highest
scoring interactions (score ≥ 0.88) and a subset containing all other interactions (score
< 0.88). Then, we compared the fraction of PPIs in each HIPPIE subset that was
recalled by the novel dataset. If the scores are meaningful one would expect better recall
of the set with high-confidence scores.
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Figure 3.1: Coverage of HIPPIE v1.2 and overlap by three technique-specific
datasets.
To measure the recall of HIPPIE by an external dataset of PPIs we considered that
some PPIs from HIPPIE may not be detectable by the experimental setup used to
produce the external dataset: in case of the MSe, the set of bait proteins was given, so
all interactions from HIPPIE in which at least one of these bait proteins was participating
were considered to be detectable PPIs. For the Y2H experiments, we chose as detectable
PPIs all interactions in HIPPIE where both interacting proteins were also found to
participate in interactions of the experimental set. The number of detectable PPIs and
the recall (Table 3.2) were used to calculate chi-squared tests to assess the significance
of the differences in recall between high and low confidence HIPPIE subsets. The high
quality subset had the largest overlaps in percentage with the PPIs of the novel datasets
and these overlaps were significant (p-values of 8.2e-12, 2.2e-16 and 9.9e-14 for Y2He1,
Y2He2 and MSe, respectively) suggesting that the PPI score correlates with experimental
reproducibility.
To compare the performance of the HIPPIE score with the confidence score of MINT,
we contrasted the recall of detectable PPIs for both scoring schemes (Table 3.2). For
all tested studies, the recall of the detectable interactions was larger for PPIs with high
HIPPIE scores than for PPIs with high MINT scores. Accordingly, the fraction of PPIs
found in the studies among the low scoring detectable PPIs was higher when the MINT
scoring scheme was applied than for the HIPPIE score.
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HIPPIE MINT
HC Other HC Other
Number interactions 3818 69319 945 17555
Y2He1 Detectable PPIs 142 944 40 296Overlap (recall) 40 (0.28) 80 (0.08) 9 (0.23) 30 (0.10)
Y2He2 Detectable PPIs 821 9135 183 2884Overlap (recall) 98 (0.12) 198 (0.02) 17 (0.09) 90 (0.03)
MSe Detectable PPIs 71 1060 13 322Overlap (recall) 20 (0.28) 53 (0.05) 3 (0.23) 17 (0.05)
Table 3.2: Coverage of HIPPIE v1.2 and MINT (version from 06/02/12) by
novel datasets. Both databases are split into a high confidence set (HC) containing the
5% highest scoring interactions and a set consisting of all other PPIs. Only interactions
that could potentially be detected by the design of the study are considered and the recall
of these interactions is calculated. For all studies tested, the recall of the high-confidence
detectable interactions was larger for HIPPIE than for MINT.
3.3 Impact of study design on network topology
It is a common network analysis task to identify hub proteins that are characterized
by many interaction partners (see Chapter 2 for several examples) or to draw general
conclusions from the degree distribution of sets of proteins (in Chapter 5 we will relate
degree characteristics of a group of proteins to their function). These analyses are usually
done on integrated PPI networks such as HIPPIE. We were wondering to which extent
the fact that some proteins are chosen as baits more often than others will bias the
observed degree distributions. An important question would be if proteins with many
interaction partners are necessarily true hub proteins or if they are just proteins that
are studied more intensively.
Bait proteins are labeled as such in the manually curated PPI database IntAct, which
was used among others to assemble HIPPIE. We retrieved this information for 47,909
pairwise interactions and assembled a list of 4233 bait proteins associated to the number
of studies in which they were examined for interaction partners. This list does not cover
all PPI experiments that contribute to HIPPIE so it only gives a lower bound for rates
at which proteins have been studied. However, due to the large number of annotated
experiments, we expect that this analysis gives a good approximation of the frequencies
with which proteins are screened for interaction partners.
We found that the bait usage distribution can be significantly well fitted to a power
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Figure 3.2: Bait usage statistics. The number of times a protein has been screened
for interaction partners can be approximated with a power-law distribution.
law distribution with exponent γ = 3.04 for number of baits ≥ 3 (Figure 3.2) using the
method of Clauset et al. (2009) (for estimating parameters and associated uncertainty).
As it is characteristic for a power-law distribution, we observed several proteins being
used many times (for example, TP53 was used as a bait in 66 PPI screens) while the ma-
jority of proteins have been used as a bait in only one study. Using ConsensusPathDB
(Kamburov et al., 2011) we tested the bait proteins for enrichment of functions and
pathways considering only categories enriched with a q-value (the false discovery rate
adjusted equivalent to the p-value) below 0.01. In accordance with a previous study
(Futschik et al., 2007) that investigated functional categories enriched among entire net-
works, we found a strong enrichment of proteins with nuclear localization, involved in
cell cycle and metabolism (q < 0.0001) among the proteins used as baits. When calcu-
lating the enrichment of functional terms and pathways among 197 proteins frequently
used as a bait (more than four times) relative to that of the full bait list, most strongly
enriched were "pathways related to cancer" (q < 10−32). While the enrichment of nuclear
proteins in the entire bait set might be caused by a technical detection bias of the still
predominantly used Y2H assay, which requires nuclear localization of the bait and prey
proteins, the strong enrichment for cancer pathways in the frequently studied bait set
clearly indicates a selection bias towards proteins with high biomedical relevance.
To test if the intuition holds that intensively studied proteins have more interaction
partners than less intensively studied proteins, we calculated the correlation between
the degree and the number of experiments in which the protein was used as a bait.
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Indeed, we observed a positive (Pearson) correlation (r = 0.552) that is not very high
but significantly deviates from random expectation (p < 10−16). Also, this correlation is
higher than the previously described correlation between protein abundance and degree,
ranging for different TAP/MS networks from 0.21 to 0.46 (Ivanic et al., 2009). This in-
dicates that it might be problematic to consider proteins with many interaction partners
in integrated PPI networks as hubs without controlling for the non-uniform bait usage
distribution. In Chapter 5 we will address this problem and present two strategies to
address the impact of selection bias on the degree distribution.
Next, we asked if pairs of intensively studied proteins are more likely reported to
interact. For this purpose, we compared all protein pairs where both proteins were used
in at least five studies and observed that a total of 1770 interactions was realised among
the 19503 possible combinations (including self-interactions), which gives a rate of 9.1%.
In comparison, among all possible combinations of proteins used only once as a bait a
much lower frequency of 0.2% were observed to interact. To test if this observation was
only caused by the higher degree of well studied proteins (assuming that two proteins
with more interactions have a higher chance to interact with each other under random
conditions), we randomly sampled protein sets of the same size as the set of the most
highly studied bait proteins while preserving the degree distribution of the proteins in the
set and counted realized interactions between proteins within these sets. Doing this, we
found the interaction number within the set of highly studied bait proteins significantly
larger than expected by chance (p < 0.001) and therefore conclude that this cannot be
solely attributed to the higher degree of well studied proteins.
One explanation for the high association of well studied proteins might be the func-
tional bias within these protein sets. Since many proteins share pathway membership
in cancer related pathways, they are more likely to interact. On the other hand, this
high number of internal associations can be caused by the biased selection strategy in
combination with experimental methods that are associated with high error rates: if
certain protein pairs are repeatedly tested, a noisy assay with high false-positive rates
will report their interaction sooner or later.
We examined the score distribution of interactions within the set of highly studied
bait proteins and among proteins only studied once (Figure 3.3). We found the score
distribution of the interactions among highly studied proteins significantly larger (p <
10−16) and, interestingly, having a larger variance (s2 = 0.019) as compared to the
proteins not frequently studied (s2 = 0.011). Also, the former distribution has a rather
bimodal shape. Closer inspection of interactions with confidence scores in the lowest
and highest quartile revealed that more than 85% of the interactions with a high score
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Figure 3.3: Confidence score distributions for interactions between inten-
sively (A) and rarely (B) studied proteins.
among proteins frequently screened were detected with multiple low throughput methods
(such as affinity chromatography technique or reconstituted complex) while the low
scoring interactions were usually poorly annotated or had experimental descriptions
that were assigned low weights by our experimental assignment scheme. Due to the
design of the confidence score, the high fraction of reliable methods among the high
scoring interactions is not surprising but, again, illustrates the necessity for evidence-
based filtering that might be able to reduce the effect of repeated testing of the same
proteins with erroneous methods.
In summary, the biased selection of proteins for interaction screening has a significant
impact on the network’s degree distribution, hampering strategies that identify hub
proteins using only the reported interaction amount. Additionally, pairs of intensively
studied proteins are more often reported to interact than expected by chance.
3.4 Implementation of the HIPPIE web tool
3.4.1 Design
We implemented a web interface that allows one to query and analyze the PPI data stored
in HIPPIE. The web layer of HIPPIE was implemented in PHP. For graph visualization it
embeds the network viewer Cytoscape Web (Lopes et al., 2010). The PPIs and associated
meta data are stored in a MySQL database. Network analyses on the PPI data (as will
be described in Chapter 4) are performed using Python and the graph algorithm library
NetworkX (Hagberg et al., 2008). Several components of the query interface (such
as the tree structure for the selection of functional filters described in Chapter 4) are
implemented in JavaScript making use of the libraries jQuery and dynatree. The HIPPIE
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Figure 3.4: Summary of HIPPIE query options and the various ways to out-
put the generated networks.
update routine is implemented in Java. Via PSICQUIC (Aranda et al., 2011) it accesses
those source databases that implement a programmatic interface (see Table 3.1). It
automatically integrates the retrieved PPI data, rescores the entire PPI repository based
on the updated evidence records and releases bulk download files of the newly generated
HIPPIE version. Additionally, we implemented several tools in Java that allow one
to execute some of HIPPIE’s analysis tasks locally for larger input sets (see following
section). The web tool can be found at http://cbdm.mdc-berlin.de/tools/hippie.
3.4.2 Query options
The HIPPIE web tool allows one to access and query the PPI data in different ways.
The query and output options are summarized in Figure 3.4. In the most simple case,
HIPPIE can by queried using a single gene symbol, Entrez gene ID or UniProt identifier
(ID and accession) (see the protein query interface in Figure 3.5). On the result page, a
confidence score is listed with each interaction partner of the query protein and detailed
information about the evidence contributing to the confidence score can be accessed.
Links to the original studies are provided. For each interaction a link is given that
generates a new HIPPIE query with the interaction partner as an input.
A typical problem after the generation of experimental results that produce a list of
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genes, proteins and/or interactions between them, is the evaluation of the results in
relation to the already known PPI data. For example, a researcher may have obtained
proteomics data for a few proteins of interest and wants to evaluate the novelty of the
interactions, or the possible relation of the interactors with a disease-related protein of
interest. Two query options facilitate this analysis. (a) A list of interactions can be
uploaded to HIPPIE and for each interaction it is indicated if the PPI has been reported
in the literature before (i.e., if it is found in HIPPIE) and for known interactions the
confidence score is reported. (b) Additionally, HIPPIE can be queried with a set of
proteins and/or interactions between them from which a network of known data around
the proteins of interest is constructed. The online tool will identify interactions between
the proteins submitted (layer 0 network), or their interactors not contained in the query
set (layer 1 network). The computation of networks with more layers might be lengthy if
hundreds of protein partners have to be analysed. For this we provide a Java command
line tool (available from http://cbdm.mdc-berlin.de/tools/hippie and also deposited at
the SourceForge open software archive: https://sourceforge.net/projects/hippiecbdm)
that will perform the computation on the user’s local machine for large input sets or
neighbours of neighbours. A confidence threshold to control the reliability and size of
the constructed network can be also applied. Additionally, we provide a filter option
for the PSI-MI interaction type annotation provided by most of the source databases of
HIPPIE. This feature allows for selecting direct physical interactions from HIPPIE. The
resulting HIPPIE subnetworks can then be displayed in tabular format, exported from
HIPPIE to a text file for further analyses or can be visualized using the tool Cytoscape
Web (Lopes et al., 2010), which has been integrated into HIPPIE. In the visualization
mode several types of information associated with proteins and interactions are visually
encoded. For example, the color of edges in the generated network indicates which
interactions have been uploaded and if they are present in HIPPIE (in Chapter 4 we will
present an example of HIPPIE’s visualization options).
The web site also offers the entire HIPPIE dataset for download in two different
formats: in PSI-MI TAB 2.5 format as defined by the Protein Standard Initiative (Her-
mjakob et al., 2004) and in our own tab delimited flat file format. Detailed usage
instructions and description of the features of the HIPPIE web tool are available at the
HIPPIE web page (http://cbdm.mdc-berlin.de/tools/hippie).
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Figure 3.5: Protein query page of the HIPPIE web tool.
3.5 Discussion
In this chapter, we presented a method to score PPIs based on the experimental evidence
supporting the interaction as well as its implementation in HIPPIE, an integrated dataset
of human protein interaction data with associated confidence scores. This resource
has been created for researchers that need to use the complete knowledge of human
protein interactions. This is required in systems biology studies and in the evaluation of
high-throughput results (e.g., novel PPI datasets) that require contrasting results with
interactions selected for a particular level of reliability.
HIPPIE currently (version 1.4; August 2012) integrates 109,670 interactions from sev-
eral public PPI resources scored according to confidence. For comparison, the complete
human interactome map has been estimated to contain between 130,000 and 260,000
interactions (Hart et al., 2006; Venkatesan et al., 2009). Considering the expected high
frequency of false-positives among the low scoring interactions, this suggests that our
knowledge of the human interactome is still incomplete. Nevertheless, producing a large
collection of integrated PPI data is critical for its usability because novel high-throughput
PPI datasets often contain just a few hundred PPIs and might have little overlap with
smaller existing PPI resources integrated in HIPPIE.
HIPPIE has been used for the evaluation of existing novel PPI datasets showing that
it increases their coverage over individual resources and that its scoring scheme corre-
lates with the ability to find a PPI in experimental data not included in the database
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(Table 3.2).
Several resources have been created that, like HIPPIE, integrate PPI data from mul-
tiple sources but do not have a focus on distributing a scored dataset, while offering
excellent tools to examine the evidence supporting each PPI. Examples include iRefWeb
(Turner et al., 2010) and UniHI (Chaurasia et al., 2007). STRING (Szklarczyk et al.,
2011) offers a confidence score weighting functional associations but does not focus on ex-
perimentally verified interactions. MINT (Ceol et al., 2010) provides an evidence-based
confidence score similar to ours. However, as a manually curated resource it covers only
a fraction of the interactions stored in HIPPIE. We also showed that our score optimiza-
tion leads to a better correlation with experimental reproducibility than for the MINT
score.
We are aware that any assignment of reliability scores to experimental techniques
necessarily reflects the individual beliefs of researchers. We tried however to base our
selection of parameters and weights in the scoring formula on objective criteria by op-
timizing the performance of our scoring scheme to assign high values to reproducible
interactions. For researchers who nevertheless wish to modify either the selected param-
eters or the scores assigned to the different techniques we offer a tool at the HIPPIE
homepage that allows the rescoring of interactions in HIPPIE using a different set of
parameters.
Investigating the effects of integrating a large number of studies (currently 27,788) on
the usage statistics of proteins, we show that the bait usage distribution does not con-
verge towards a uniform distribution. On the contrary, a few proteins have been screened
multiple times and the majority only once or never. This bias has both functional and
topological implications. The here described correlation with the degree distribution is
stronger than the previously reported correlation between protein abundance and degree
(Björklund et al., 2008; Ivanic et al., 2009). Few studies exist that aim at controlling for
the selection bias (an exception is Dickerson et al. (2010)). Our analyses suggest that
previous studies that draw conclusions from the degree distribution of integrated PPI
networks (for example those of Wachi et al. (2005) and Jonsson and Bates (2006), which
described a higher number interaction partners for cancer proteins based on an analysis
of integrated networks) need to be carefully re-examined. In Chapter 5 we will use the
HIPPIE network to study the properties of polyQ-containing proteins, some of which
are involved in neurodegenerative diseases and therefore have been extensively studied.
In this analysis, we will demonstrate how important it is to take the here described
selection bias into account.
Providing a tool to select interactions based on their amount of experimental evidence
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helps to provide PPI networks of higher reliability. Still, the problem remains that
even interactions that are reproducible under artificial experimental setups might never
or only under certain conditions be realised. In a recent study (Lopes et al., 2011)
we showed that applying tissue expression filters to subnetworks of HIPPIE around
human proteins that directly interact with viral proteins, we strengthen the enrichment
of pathways known to be involved in the respective disease caused by the virus. In
Chapter 4 we will extend this idea and show how the incorporation of functional and
expression information into PPI networks leads to the detection of PPIs that are not
only experimentally more reliable but also show a high relevance to human disease.
3.6 Contributions
This chapter is a modified and extended version of Schaefer et al. (2012a). The described
integration of PPI data, design and optimization of a scoring formula and implementation
of a web tool were done by me. The evaluation of PPI detection methods (Appendix A,
Table 1) was done by our experimentally working collaboration partners (Pablo Porras
and Erich Wanker). The original paper was written by Miguel Andrade and me. The
study of the network topology and the performance comparison with existing approaches
(which are not part of the publication) were performed and written by me.
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4.1 Motivation
The advent of high-throughput techniques to measure and perturb molecular species
in a systematic way has enabled researchers to assess the different layers of cellular
metabolism under different experimental conditions. In Chapter 3 we integrated a large
PPI network and developed a strategy to deal with the high error rates associated
with PPI data. Another major drawback of these data is that the artificial expression
systems used to reconstruct PPI networks do not take into account two of the many
factors that are essential to understand the biology of the cell: first, the time-point at
which the proteins are expressed (e.g., cell-cycle or developmental stage) and second,
the tissue or intracellular compartment where the proteins are expressed or located
(different organs and tissues have very specific protein compositions). Therefore, two
proteins may be reported as interaction partners, although they are expressed in different
tissues or at different time-points. While high-throughput studies acknowledge these
caveats, PPI databases collect these data without mechanisms explicitly directed to
discern the biological plausibility of a reported interaction. Therefore, the selection of
proteins expressed in a specific cell type or compartment would allow the generation of
subnetworks that would more realistically represent biological processes in the respective
cell types or cellular compartment.
Several attempts have been made to investigate the tissue-specific binding behavior
of single proteins and the spatio-temporal dynamics of PPI networks (Agarwal et al.,
2010; Bossi and Lehner, 2009; de Lichtenberg et al., 2005; Han et al., 2004; Taylor et al.,
2009; Wen-hsien et al., 2009). In a recent study evaluating the characteristics of publicly
available PPI databases, we demonstrated that the use of subnetworks (which include
only interactions of proteins expressed in the same tissue) identifies potential mechanisms
or pathways that would remain obscured if the complete PPI database was used (Lopes
et al., 2011).
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In addition, many proteins have multiple functions, carried out in cooperation with
distinct sets of interacting partners. Networks of interacting proteins with coherent
function have been termed context networks (Rachlin et al., 2006). Here, we adopt this
notion of context and extend it to PPIs or networks of proteins being expressed in the
same tissue or cooperatively transmitting signal flow. There is a lack of studies testing
systematically the potential of adding context information to PPI networks in recovering
meaningful PPI subsets and, although there are a few approaches that allow to add ex-
pression or functional information to PPI data (Chowdhary et al., 2012; Lee et al., 2009;
Yang et al., 2008), convenient methods for the creation of such context-specific subnet-
works are generally missing. In this chapter, we introduce an approach to add context
to PPI networks using annotations and relations between the interacting partners and
demonstrate that context-specific PPI networks are enriched in high-confidence interac-
tions. We use this approach to investigate how the proteins of the human influenza virus
interfere with the immune response of the host cell in a tissue-specific manner, finding
novel potential regulators of influenza virus pathogenicity, and to study the brain-specific
signaling pathways that play a role in Alzheimer’s disease, identifying a pathway involv-
ing the altered phosphorylation of the Tau protein. Thereby, we illustrate how the
addition of context to PPI networks can guide researchers in the discovery of meaningful
interactions and pathways, which would otherwise be obscured by the vast amount of
irrelevant (for a specific question) and partly erroneous amount of PPI data.
4.2 Context-specific and directed protein-protein interaction
networks
We inferred context information for all interactions in the human PPI database HIPPIE
described in Chapter 3. In a first step, we associated all proteins in HIPPIE with the
following attributes: tissue-expression, GO biological process and cellular compartment,
and inferred annotations for the MeSH categories disease and tissue. Proteins were
associated with tissues (based on their gene expression profiles retrieved from BioGPS
(Wu et al., 2009) and using the method defined by Lopes et al. (2011)) or annotated as
housekeeping (using a list from Eisenberg and Levanon (2003)). Next, associations with
biological processes and subcellular locations were determined according to the EBI GO
annotation (release from October 28, 2011; reduced to GO slim terms) (Dimmer et al.,
2012), and to MeSH terms belonging to "Diseases" (class C) or "Tissues" (class A10)
that annotate the biomedical references associated to them in MEDLINE (release 2012;
gene2pubmed at NCBI ftp site).
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We then inferred context associations to the PPIs according to the annotations of the
interacting proteins and taking into account the hierarchical structure of GO and MeSH
terms. We associated an interaction with a tissue when both interactors are expressed
in the same tissue (e.g., "lung"). Given a term of a functional ontology, we associated an
interaction with this function when both interactors are annotated with either the given
functional term or with children of it in the hierarchy of the ontology. For example,
the GO term "transport" would be associated with an interaction between a protein
annotated as involved in "vacuolar transport" and another protein annotated as involved
in "nucleocytoplasmic transport". We excluded the rather unspecific top-level terms
"biological process", "cellular component" and "cell". Additionally, we ignored categories
that are associated to less than 20 interactions.
We implemented filters for the HIPPIE web tool that allow to generate context-specific
subnetworks by selecting the respective category (see Figure 4.1). Additionally, HIPPIE
implements the prediction of information flow and edge directionality. This is done as-
suming that signal pathways follow the transmission of information through interacting
proteins starting in cell surface receptors that collect external cues and ending in tran-
scription factors as final effectors on gene regulation, following Vinayagam et al. (2011).
All pairwise shortest paths between proteins annotated with the GO term "receptor"
and "sequence-specific DNA binding transcription factor activity", respectively, in the
UniprotKB (Magrane and UniProt Consortium, 2011) were computed. An edge of the
network was considered to be directed if at least one shortest path goes through that
edge. The direction of the path (from source to sink) determined the direction of the
edge. Edges with conflicting orientations of passing paths were not assigned direction-
ality.
The HIPPIE web tool allows users to specify generic source and sink sets (instead of
receptors and transcription factors) between which the shortest paths are computed in
output networks that result from a HIPPIE query. We do not consider edge weights
and, hence we are able to determine each shortest path in linear time via a breadth-first
search.
Overall, we were able to associate context to 95% of the more than 100,000 interactions
of the current version of HIPPIE (only considering function and tissue expression, not
the edge directions). Interactions for which we inferred or collected annotations had
significantly better experimental evidence (Figure 4.2). This suggests that annotated
interactions might have higher biological significance than non-annotated ones.
We observed that more specific context categories were associated to interactions
with higher experimental reliability: while the confidence scores of interactions with
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Figure 4.1: Generation of context-specific PPI networks with the HIPPIE
web tool. Various query options allow to filter for edge annotations.
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Figure 4.2: Context-associated interactions have in average a higher confi-
dence score than non-annotated interactions. The numbers in the bars indicate
the mean experimental score of the non-annotated fraction (above, black font) and of the
annotated fraction (below, white font), respectively. All mean-score differences between
annotated and not annotated interactions were significant (p < 0.001; Mann-Whitney-
test).
rather unspecific and ubiquitous terms resemble the overall confidence score distribution,
interactions with highly specific terms usually have a higher than average confidence
score (Figure 4.3). For example, the 43,372 interactions associated with the GO category
"cytoplasm" (of depth 1 in the GO hierarchy) have an average confidence score of 0.675
as compared to the average of 0.670 over all interactions. On the other hand, the
159 interactions associated with the (depth 3) GO category "ribonucleoprotein complex
assembly" have a high average confidence score of 0.754. We observed a similar tendency
for more specific MeSH terms to have a higher experimental reliability.
To demonstrate that our automated context association approach allows identification
of relevant interactions, we tested if networks of interactions of our inferred MeSH-based
disease-annotation are enriched in well-known disease proteins. Therefore, we repeatedly
generated disease-context networks around a set of canonical disease proteins and ex-
amined if these networks included other known disease-related proteins. As a canonical
disease protein specification, we retrieved the manually curated UniProt Knowledgebase
disease protein annotation. For each of the canonical disease proteins, we generated two
types of networks: (a) disease networks consisting only of interactions of the disease pro-
teins that we had associated with the equivalent MeSH disease term and (b) unfiltered
PPI network consisting of all interactions of the disease protein from HIPPIE. We did
this for all disease proteins where the disease was associated with at least two disease
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Figure 4.3: More specific edge annotations are associated with higher exper-
imental confidence scores. The box plots visualize the distribution of experimental
scores of PPIs associated with GO (left) and MeSH (right) term categories. (Top) The
scores for GO and MeSH terms decreased generally for less specific terms (the only ex-
ception was GO terms depth 2, which was associated with interactions of a lower mean
confidence as compared to GO terms depth 1). (Bottom) GO and MeSH terms were
subdivided in quartiles according to the number of interactions annotated for each cate-
gory (from low, Q1, to high number, Q4). The scores decreased for terms associated to
higher numbers of interactions.
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proteins in UniProt and at least two interactions that we had associated with this disease.
To quantify the enrichment of disease proteins in these networks, we repeatedly calcu-
lated the F1 score, the harmonic mean of precision and recall (F1 = 2∗precision∗recallprecision+recall ). A
one-sided Mann-Whitney-test comparing the distribution of F1 scores between the dis-
ease networks and the non-filtered networks indicated that the F1 scores for the disease
networks were significantly larger (p < 0.05) proving an enrichment of disease proteins
in the disease filtered networks (without losing sensitivity by removing disease proteins
in the filtering step). The mean precision on the filtered networks was 0.47 and on the
unfiltered networks 0.21. The mean recall for the filtered networks was 0.14 and for the
unfiltered networks 0.15. This illustrates that in return for a small decrease in recall the
precision can be more than doubled by applying the MeSH disease filter.
We then investigated the potential of edge directionality inference based on the short-
est paths between membrane-bound receptors and transcription factors through the PPI
network to recover known pathways. We retrieved pathway annotations (extracted from
WikiPathways download March 29, 2012) and computed the shortest path through HIP-
PIE between all pairs of receptors and transcription factors within the same pathway
(excluding only pairs that directly interact or could not be connected by any path). We
counted the number of proteins of each pathway found on the shortest path (excluding
the source and the sink node between which the shortest path was computed). We found
for 3163 of the 5063 pairs that this approach correctly identified proteins of the selected
pathway. The mean precision (the fraction of proteins on the paths that indeed belonged
to the correct pathway) over all combinations of receptors with transcription factors was
0.20. The mean recall (the fraction of the pathway that was recovered by considering
the paths between one receptor and one transcription factor) was 0.02.
To assess if the agreement between shortest paths and canonical pathways was larger
than expected by chance, we generated a background distribution by computing repeat-
edly the shortest paths between a receptor and a transcription factor from different
pathways and computed the overlap between the proteins on the shortest path to either
the transcription factor- or the receptor-containing pathway. We found that the overlap
distribution was significantly higher when the receptor and the transcription factor were
members of the same pathway (p < 0.001; Mann-Whitney-test) proving the potential of
shortest paths to recover the signal flow between transcription factors and receptors.
We wondered if we could further increase the overlap between the shortest paths and
the canonical pathways by filtering the networks for tissue expression. To associate
pathways with tissues, we determined for each pathway which tissues were more than
two-fold enriched among the genes of the pathway (using again the earlier described
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association between tissues and genes). Inspection of the tissues enriched among proteins
forming a pathway revealed that in many cases they indeed reflect plausible locations
for pathway activity. For example, immune response pathways were enriched among
blood cells, and pathways associated with neurodegenerative diseases and addiction were
enriched in brain-related tissues.
We repeated the computation of shortest paths linking receptors to transcription fac-
tors in tissue-specific networks for all combinations of pathways and tissues and for all
pairs of receptors and transcription factors that were expressed in the respective tis-
sue. Indeed, we observed an increase of the mean precision to 0.24 (as compared to a
precision of 0.20 for the unfiltered networks), which shows that we could enhance the
agreement between shortest paths and canonical pathways by computing the shortest
paths in tissue-specific networks. The recall increased from 0.02 to 0.03, which is still
a low value but not surprising since many pathway-related proteins were not present
in the considered tissue-specific networks and, hence, could not be detected. Again,
the amount of pathway proteins on the tissue-specific shortest path between receptors
and transcription factors from the same pathway was significantly larger as compared
to shortest paths between receptors and transcription factors from different pathways
(p < 0.05).
To further investigate if the described context-associations can help to extract pathway
information from networks, we compared the frequency of protein pairs being members
of the same pathway (as defined by WikiPathways) among tissue-specific PPIs (both
proteins where required to be co-expressed in at least one tissue) and to the frequency
among PPIs between proteins that are not expressed in the same tissue. We observed
that interacting protein pairs that are expressed in the same tissue are indeed more likely
to be in the same pathway as compared to interacting protein pairs that are expressed in
disjoint sets of tissues (p < 0.001). This, again, demonstrates that the annotations have
captured properties related to pathways and suggests that the filtering helps revealing
pathway information.
In the next sections we use the context-associated PPI network to obtain novel in-
sights into the mechanisms of human disease: we perform a targeted study of the PPI
network surrounding the human proteins that interact with influenza virus proteins to
find potential regulators of viral pathogenicity, and we explore the question of whether
and how altered protein phosphorylation might be a cause of Alzheimer’s disease.
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Figure 4.4: Tissue-specific PPI subnetwork of human proteins interacting
with influenza virus proteins. (A) Influenza proteins (red) interact with 23 first
layer host proteins (blue). These first layer proteins have interaction partners that are
specific for the bronchial epithelial tissue (BET) subnetwork, for the lung subnetwork
or are shared between both subnetworks (all in green).
4.3 Context-specific influenza host factor networks
We analyzed PPI data of human proteins that interact with influenza virus proteins.
Influenza viruses infect bronchial epithelial tissue and many cell types in the lung, some-
times resulting in viral pneumonia (Fields et al., 2007). We started by obtaining a list
of 87 human proteins that have been shown to interact with at least one influenza virus
protein in a previous study (Shapira et al., 2009). From this list, we observed that 23
proteins were expressed in bronchial epithelial tissue (BET), in whole lung, or in both
tissues - we refer to these proteins as first layer host factors. We created the second layer
by filtering tissue-specific proteins (expressed in BET or whole lung) that interact with
members of the first layer (Figure 4.4). Together, the first and second layers compose
the tissue-specific PPI subnetworks.
Next, we analyzed the BET- and lung-specific PPI subnetworks using pathway en-
richment analyses, and found both similarities and differences in the cellular functions
of each. We performed pathway enrichment analysis with ConsensusPathDB (run on
August 30, 2012; (Kamburov et al., 2011)). We used a cut-off of 0.05 on the q-value (the
false discovery rate adjusted equivalent to the p-value). The background control for the
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tests was the complete list of proteins annotated as expressed in the given tissues (and
with PPI information in HIPPIE).
Both subnetworks showed enrichment for processes related to programmed cell death
and eukaryotic translation. These results are consistent with functions known to be
activated or disrupted by influenza virus infection (Ehrhardt et al., 2010; He et al., 2010;
Ludwig et al., 2006). In addition, proteins in the BET subnetwork exhibited a stronger
signature in processes involved with transcriptional regulation, sumoylation, and the
regulation of mRNA stability (in particular, the stability of AU-rich element-containing
mRNAs). Although these processes tend to be associated with general housekeeping
functions, we point out that many cytokine and interferon mRNAs contain AU-rich
elements (Khabar, 2005). This observation suggests, hypothetically, that influenza virus
proteins may function to dysregulate cytokine mRNA stability in BET, a function that
could impact influenza virus pathogenesis through modulation of immune cell infiltration
and function. In relation to sumoylation, it has been noted recently that influenza
virus can gain protein functionality during infection by interacting with the sumoylation
system of the host cell (Pal et al., 2011). On the other hand, the lung subnetwork was
uniquely enriched for processes related to cell-substrate adhesion (pathway "signaling
events mediated by focal adhesion kinase"). Because cell adhesion is important for
maintaining cellular viability and epithelial barrier function, it is possible that influenza
virus protein-mediated interference with this process could impact both the amount
of virus-inflicted damage upon the lung and the dissemination of influenza virus into
extra-pulmonary sites.
Cells respond to influenza infection by producing cytokines and chemokines (Adachi
et al., 1997; Matsukura et al., 1996), while viral proteins counteract this innate immune
response. One example of a viral protein directly interfering on the protein level with
cellular immune pathways is NS1 (its involvement in immune response suppression is
reviewed in Hale et al. (2008)), which inhibits double-stranded-RNA-activated antiviral
protein kinase (PKR). It is interesting to note that the lung subnetwork was also enriched
for the "TLR JNK", "TRAF6 mediated IRF7 activation in TLR7/8 or 9 signalling", "IL-
1 JNK", "TLR ECSIT MEKK1 JNK", and "IL1-mediated signaling events" pathways,
because none of these are known to be specifically perturbed by viral proteins. IRAK1
(IL-1 receptor-associated kinase 1), which plays a critical role in IL-1 signaling events
and in the activation of toll-like receptor (TLR) 7 and 9 pathways (reviewed in Gotti-
pati et al. (2008)), is shared by all of these pathways. In non-stimulated cells, IRAK1
is associated with toll-interacting protein (TOLLIP), which is also part of the pathways
listed above (with the exception of the "TRAF6 mediated IRF7 activation in TLR7/8 or
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signalling" pathway). Stimulation of the IL-1 or TLR receptors leads to MyD88 (found
in all pathways listed above) recruitment to the receptors. Through its interaction with
MyD88, IRAK1 is also recruited to this complex. Complex formation results in IRAK1
phosphorylation and the activation of its kinase activity. Activated IRAK1 phosphory-
lates IRF7 or associates with TRAF6, resulting in IFNα induction and NFκB/MAPK
activation, respectively. IRAK1 thus plays a critical role in innate immune responses,
and the enrichment of IRAK1-dependent pathways in the lung network may contribute
to the regulation of lung pathology in influenza virus infection.
A recent study demonstrated that signaling through the IL-1 receptor has a pro-
tective effect in mice infected with the pandemic 1918 influenza virus (Belisle et al.,
2010). Another study reported that IL-1 receptor-deficient mice succumbed more eas-
ily than wild-type mice to infection with an H5N1 virus of low pathogenicity (A/Hong
Kong/486/1997) (Szretter et al., 2007). Moreover, IL-1 receptor-deficient mice showed
reduced inflammatory pathology upon infection with A/Puerto Rico/8/34 (H1N1) in-
fluenza virus (Schmitz et al., 2005). Several studies also established that influenza virus
infection is sensed by TLR7 in plasmacytoid dendritic cell (Diebold et al., 2004; Geer-
aedts et al., 2008; Liang et al., 2011; Lund et al., 2004; Miettinen et al., 2001; Xing et al.,
2011). However, none of these studies addressed the significance of IRAK1 in influenza
virus pathogenicity. Our study thus exemplifies how our network analysis can identify
potential regulators of influenza pathogenicity for experimental testing, for example, by
assessing influenza virus infections in IRAK1-deficient cells or mice.
Next, we aimed to predict more specific novel interference mechanisms by constructing
directed and tissue-specific protein networks linking the viral proteins with proteins
whose corresponding transcript was up-regulated after influenza virus infection. We
selected steadily up-regulated transcripts from a microarray experiment measuring gene
expression changes over time in a lung epithelial cell line infected with a 2009 pandemic
H1N1 virus (Li et al., 2011). To select steadily up-regulated genes, we filtered for probes
differentially expressed at the last three time-points in the time series (30, 36 and 48h)
with a q-value lower than 0.01 and a log2 fold change greater than 1. We selected 228
up-regulated transcripts in total.
As expected, all ten most strongly enriched pathways among the selected transcripts
were involved in infection and the immune response. For example, most highly overrep-
resented was interferon alpha-beta signaling (p < 10−20).
We constructed BET- and lung-specific networks connecting the viral proteins with
the 228 up-regulated factors by shortest paths. From the shortest paths we assigned
directions to edges on these paths (as described in section 4.2). The directed networks
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consisted of 577 (BET) and 1056 (lung) PPIs. To examine if these networks might host
relevant information on how viral proteins interfere with the cellular immune response,
we tested for pathway enrichment in the reduced networks. We found the directed
networks strongly enriched in immune response-related pathways (especially cytokine-
related) even after excluding the 228 up-regulated transcripts, indicating that enrichment
was independent of the high fraction of immune response factors in the transcriptomics
data. For example, we observed a significant enrichment in both the reduced BET- and
lung-specific networks for proteins related to IL-2 and IL-6 signaling and focal adhesions
(q < 0.05). This suggested that directed and tissue-filtered PPI networks, indeed, might
have captured relevant crosstalk between the viral proteins and immune pathways.
To mine the directed networks for interactions that are involved in interference mech-
anisms of the viral proteins with the cellular immune response, we concentrated, again,
on layer one and two host factor proteins on the shortest paths. From the list of curated
pathways enriched in both the BET and the lung directed networks, we selected several
cytokine-related pathways and filtered for interactions where the second layer protein
was in one of these pathways but the layer one protein was not (to specifically detect
novel, indirect interference mechanisms). This resulted in a comprehensive BET network
consisting of 49 interactions and a lung network formed by 67 interactions including viral
proteins and host factors up to the second layer (see Appendix, Table 2).
Close inspection of these comprehensive cytokine-related networks in both BET and
lung revealed several points of potential viral protein-mediated interference with in-
flammatory pathways. For example, both networks showed interactions between viral
polymerase complex proteins (i.e., PB1 and PB2) and BHLHE40, a transcriptional reg-
ulator that is known to cooperate with HDAC1 to repress STAT1 activity (Ivanov et al.,
2006). STAT1 is essential for the activation of interferon stimulated genes, which repress
viral replication, and while influenza virus has an established ability to impair STAT1
(Pauli et al., 2008), no such function has been assigned to any of the viral polymerase
complex subunits. In both comprehensive networks, BHLHE40 interacts with TOLLIP,
a suppressor of TLR signaling (Cario and Podolsky, 2005) (see also the discussion of
lung-specific inflammatory pathways above). This implies that the BHLHE40 protein
could act as an important access point for influenza virus-mediated interference with
host antiviral and inflammatory regulation, and further that viral polymerase subunits
may have an important - yet unappreciated - role in this activity.
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Figure 4.5: Protocol for the generation of a PPI subnetwork related to phos-
phorylation in Alzheimer’s disease. The flowchart illustrates the input terms and
options used to generate the network (see main text for details).
4.4 Search for phosphorylation-dependent protein-protein
interactions related to Alzheimer’s
Assuming no prior expert knowledge on a given topic, we applied a systematic protocol
which can, in principle, be used to interrogate the PPI network about the involvement
of protein interactions in a complex biological question according to current knowledge.
In general, altered states of protein phosphorylation affect the PPI network and can
lead to pathogenesis. Our goal in this example was to investigate the possible role of
protein phosphorylation in Alzheimer’s disease, the most common form of dementia.
Alzheimer’s disease is a degenerative disease manifesting in the brain, and its cause has
been hypothesized to be the formation of protein aggregates leading to neuron death, in
particular related to the abnormal phosphorylation of the microtubule-associated protein
tau (Chun and Johnson, 2007).
To generate a list of PPIs related to Alzheimer’s and protein phosphorylation, first,
we used the webserver MedlineRanker (Fontaine et al., 2009) to retrieve a list of ranked
PubMed abstracts (corresponding to manuscripts published within the last 5 years)
according to their relevance to the search term "Alzheimer phosphorylation", which re-
lates loosely to the question of interest. Next, we input the top 50 abstracts from
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MedlineRanker into the webserver PESCADOR (Barbosa-Silva et al., 2011), which ex-
tracts a network of potential PPIs based on a set of PubMed abstracts. In our ex-
ample, PESCADOR outputs 10 interaction pairs (type 2; co-occurrence of genes or
proteins within a sentence containing a biointeraction term), of which only 4 pairs ex-
isted in HIPPIE as scored interactions (PSEN1:PSEN2, GSK3B:MAPT, APP:BACE1,
PPP2R4:SET). We then studied the network surrounding these interactions.
The initial PPI network contained 726 interactions. Interactions could be further
filtered on the basis of reasonable criteria (Figure 4.5), namely by tissue filtering for
housekeeping and genes expressed in brain tissues (we selected "whole brain" and "pre-
frontal cortex"), and filtering for genes related to the GO term "cell death", reflecting
that Alzheimer’s disease is characterized by death of neural cells. Finally, to reveal po-
tential signal transduction pathways we used the inference of edge directionality from
receptors to transcription factors described above.
Within the resulting network, we highlighted the following path (Figure 4.6): LRP6-
GSK3B-MAPT-AATF. The low density lipoprotein receptor-related protein 6 (LRP6)
interacts with glycogen synthase kinase 3B and attenuates the kinase’s ability to phos-
phorylate microtubule associated protein tau (MAPT) (Mi et al., 2006). Tau protein
can contribute to Alzheimer’s disease in different ways: 1) the hyperphosphorylation of
tau protein can affect microtubule stability, leading to a disassociation of tau protein
from the microtubule, possibly followed by the aggregation of phosphorylated tau into
neurofibrillary tangles, which are observed in the brains of Alzheimer’s disease patients
(Dolan and Johnson, 2010); 2) mediated by protein phosphatase 1 and GSK3 activity,
Tau filaments interfere with axonal transport in the neuron, which is consistent with
deficiencies in axonal transport in Alzheimer’s disease (LaPointe et al., 2009). Tau pro-
tein has been found to co-localize in the cytoplasm with Che-1 (AATF), which is an
evolutionarily conserved RNA polymerase II binding protein that accumulates in the
cell upon DNA damage (Claudio and Maurizio, 2007). It appears that Che-1/Tau pro-
teins dissociate during neuronal cell death (Barbato et al., 2003); however, the function
of Che-1 in the cytoplasm is unclear, as Che-1 is a nuclear protein that is involved in
gene regulation of E2F1 targets and TP53 and has pro-proliferative and anti-apoptotic
functions (Bruno et al., 2010). Together, these interactions suggest a complex interplay
whereby the Tau phosphorylation state and structure, and context-dependent protein
distribution within the cell may contribute to neuronal cell death and Alzheimer’s dis-
ease pathology. An unbiased search for protein phosphorylation in relation to cell death
in Alzheimer’s disease pointed us to this interesting pathway.
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Figure 4.6: Generated PPI subnetwork related to phosphorylation in
Alzheimer’s disease. The network of the input interactions with their first neigh-
bors is shown. The input interactions are are displayed in blue and the nodes they
connect as octagons. Nodes corresponding to receptors and transcription factors are
colored (blue and pink nodes, respectively). Edge directed path analysis from receptors
to transcription factors resulted in the association of directionality to some of the edges
(arrows). The path LRP6-GSK3B-MAPT-AATF is highlighted in yellow and described
in the text. The inset shows the non-filtered network for comparison (726 interactions).
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4.5 Discussion
The incorporation of tissue-specific expression information to create PPI subnetworks is
a useful method to elucidate biological processes that cannot be observed when using the
complete PPI network. Here we have shown an approach for the inference of associated
context for PPIs based on the annotations of the interacting partners, which enhances
the relevance of the annotated interactions. Interactions between proteins expressed in
the same location (e.g., lung) or at the same time or developmental stage (e.g., embryo
development) can then be selected. Directed pathways can be inferred and highlighted
in the filtered network according to sets of sources and sinks corresponding to receptors
and transcription factors. Using this approach we were able to identify novel, tissue-
specific interactions between influenza virus proteins and cellular inflammatory signaling
pathways that may regulate pathogenesis associated with infection, and to describe a
brain-specific protein phosphorylation pathway relevant for Alzheimer’s disease.
Several methods exist to create subnetworks of the human interactome based on con-
text criteria. For example, POINeT (Lee et al., 2009) integrates the major PPI databases
and allows the creation of tissue-specific networks. To our knowledge we are the first
to combine edge directionality, gene expression and functional information for the de-
tection of meaningful interactions. Some approaches exist that infer information flow
in a network from the shortest path (or lowest costs if costs are associated with edges)
that connects a set of source nodes with sink nodes. Cytoscape plug-ins such as Biso-
Genet (Martin et al., 2010) and GenePro (Vlasblom et al., 2006) find the shortest paths
between nodes of the gene and protein network and represent properties of the nodes.
SPIKE (Elkon et al., 2008) includes curated pathway data and also calculates pathway
inference. The task of identifying signaling events from PPI data and functional protein
annotation alone has been addressed in several studies (Mah et al., 2011; Vinayagam
et al., 2011; Yosef et al., 2009) and implemented in tools (e.g., ANAT (Yosef et al.,
2011)). Here, we proposed a protocol for edge directionality prediction based on calcu-
lating the shortest paths between sources and sinks. This protocol is runtime-efficient,
which allowed us to integrate it with the web tool HIPPIE described in Chapter 3.
In summary, we have presented and made available an approach to associate context
to PPI networks, which provides novel biological insight into mechanisms of disease.
The continuing generation of PPI data and further incorporation into databases, and
an increasing quality of annotations attached to genes and proteins will result in further
improvements of our methodology.
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4.6 Contributions
This chapter is a modified version of Schaefer et al. (2013). This work is based on ideas
that we developed earlier and published in Lopes et al. (2011). In this earlier study
we showed that disease-relevant pathways are more strongly enriched among specifically
expressed (in cell types affected by the virus) interaction partners of viral proteins as
compared to all interaction partners of the viral proteins.
All computational analyses described in this chapter were done by me except for the
determination of the lowest common ancestors in the MeSH and GO hierarchies (done
by Caroline Louis-Jeune and Carol Perez-Iratxeta) and the selection of genes specifically
expressed in tissues (done by Tiago J.S. Lopes). The biological interpretation was done
jointly with our collaboration partners at the Systems Biology Institute in Tokyo and at
the University of Wisconsin-Madison. The paper was written by Miguel Andrade and
me.
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5 Evolution and function of polyglutamine
in protein-protein interaction networks
5.1 Motivation
In this chapter, we describe how we investigated the evolution and function of polyQ
stretches, which are known to cause neurodegenerative diseases when they undergo
length expansion. For example, HD is caused by a length expansion of the polyQ stretch
in the human protein huntingtin, which under non-pathological conditions ranges from
11 to 35 amino acids, to a length of over 40 residues. This drives the assembly of insol-
uble protein aggregates containing huntingtin together with other proteins. The length
expansion of polyQ leads to cell death in the striatum and other regions of the brain,
causing changes in movement and cognition (Reiner et al., 1988).
Besides their association with disease development, polyQ sequences may have an
unknown physiological role (von Mikecz, 2009). While it was hypothesized that polyQ
sequences might form a flexible spacer between protein domains like other low complex-
ity regions (Faux et al., 2005; Huntley and Golding, 2000; Karlin and Burge, 1996), they
are present in more than 60 human proteins (Butland et al., 2007), and some lower or-
ganisms, such as the amoeba Dictyostelium discoideum (Eichinger et al., 2005), possess
several hundred. Anecdotal experimental evidence suggests a role of polyQ tracts in ac-
tivation of gene transcription (Mitchell and Tjian, 1989). Accordingly, statistical studies
revealed that proteins containing a polyQ stretch are biased toward functions related to
transcriptional regulation and nuclear localization in several species (Alba and Guigo,
2004; Harrison, 2006; Karlin and Burge, 1996). Also, a more general role in mediating
protein-protein interactions has been suggested (Hands et al., 2008).
In order to advance our understanding of the functions of polyQ regions in proteins,
we investigated their potential properties from a systemic point of view. Since polyQ
repeats have functional and evolutionary features that have been proposed to be relevant
at different inter-related molecular levels, we have studied and combined analyses at the
level of nucleotide sequences, protein sequences, protein structures and protein interac-
49
5 Evolution and function of polyglutamine in protein-protein interaction networks
tion networks to obtain a systematic overview of polyQ function and evolution. We start
with the analysis of CAG repeats at the nucleotide level, moving on to the analysis of
protein sequences with polyQ tracts and phylogenetic studies of protein families, to the
investigation of protein interaction networks of polyQ-containing proteins.
Our analyses suggest that the normal function of polyQ regions in proteins is to
stabilize PPIs. We provide evidence for this hypothesis by analyzing the PPI network
described in Chapter 3. We take into account the previously described study bias, which
has a strong impact on network topological properties of well-studied proteins such as
polyQ-containing proteins. As in Chapter 4, we will make use of functional protein
annotations to generate biological hypotheses from network data. Here, we develop a
strategy to control for the high amount of transcription factors among polyQ proteins
when studying their associations to other proteins.
5.2 Distribution of CAG repeats in the human genome
Glutamines in proteins can be encoded by either CAG or CAA codons. However, the
polyQ stretches that are enlarged in human disease proteins are encoded almost ex-
clusively by pure CAG runs, while CAA repeats have not been observed (Gatchel and
Zoghbi, 2005). This led to the suggestion of a possible mechanism for their generation
by DNA slippage and hairpin formation during DNA replication, facilitating length ex-
tensions to which CAG but not CAA repeats are prone (Strand et al., 1993). This raises
the question if CAG repeats, and the polyQ encoded by them, are just artifacts of faulty
DNA replication without biological function.
This question can be answered by examining the genomic location of CAG repeats. If
their genomic location was solely determined by random processes such as copy errors
during DNA replication, and they underwent no evolutionary selection, they should be
evenly distributed in the genome. On the contrary, if they had a biological function,
their distribution should correspond to the molecular level of action: a function on RNA
level would bias their genomic position toward transcribed genomic regions whereas a
function in proteins would shift their distribution toward protein-coding exons.
We studied the distribution of CAG repeats of 10 or more consecutive trinucleotides
in the human genome (GRCh37/hg19; Karolchik et al. (2003)). To measure whether
the observed distribution is random or biased toward specific elements, we calculated
the relative number of repeats located in different regions such as protein-coding exons,
introns, untranslated regions (UTRs) and intergenic regions (conflicting assignments
for a genomic region due to different splicing forms were resolved by giving priority
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Figure 5.1: Frequency of trinucleotide repeats in the human genome. The y-
axis represents the log2 of the ratio between the relative number of repeat runs observed
(considering runs of at least 10 consecutive trinucleotides) and the proportion of the
genome that is covered by the respective genomic region type.
to assignments in the following order: protein-coding exon, UTR, intron, intergenic
region). These frequencies were normalized by the fraction of the genome covered by
the respective region type (Figure 5.1).
Indeed, of 136 CAG repeats considered, 33 are in protein coding exons, resulting in a
43-fold enrichment over a random expectation, as previously described (Kozlowski et al.,
2010). Although those 33 CAG repeats in coding regions could potentially encode three
types of amino acid repeats depending on the reading frame (polyQ, polyS and polyA,
for codons CAG, AGC and GCA, respectively), 28 coded for polyQ. This suggests that
even if CAG repeats were accidental, they are selected for the encoding of polyQ in
proteins, suggesting that polyQ has a biological function. Accordingly, the number of
CAG repeats in introns and intergenic regions is close to random expectation (8 and 89,
respectively; Figure 5.1). However, 6 CAG repeats are in UTRs (8-fold over random
expectation), including the known disease locus in the 5’-UTR of the gene PPP2R2B
causing spinocerebellar ataxia type 12 (Holmes et al., 2001), suggesting that they have
a function at the transcript level. We also found CAG repeats enriched in UTRs and
protein coding exons in rat (Baylor 3.4/rn4), mouse (NCBI37/mm9) and fly (BDGP
R5/dm3), though to a lower degree than in human (UTR enrichment ranges from 1.7-
to 2.5-fold and exon enrichment from 3.1- to 5.3-fold).
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For comparison, we did an analysis considering consecutive runs composed of both
codons encoding glutamine (CAG or CAA). These mixed trinucleotide repeats are 11
times more frequent in the human genome than pure CAG repeats. Like CAG repeats,
the mixed repeats were enriched in exons and randomly distributed outside transcripts;
their presence in UTRs, unlike CAG repeats, was close to random expectation. Together,
these results suggest that CAG repeats have a function both at the protein and the
transcript level.
We also analyzed the frequencies of pure CAA repeats in the different genomic region
types. We found them to be generally more frequent in the human genome as compared
to pure CAG repeats (1000 versus 136) but largely absent from protein coding regions
(just one CAA repeat is located in a translated region encoding a polyQ stretch in the
human protein ZFHX3). We note that there is a 2-fold enrichment of genes encoding
tRNAs with an anticodon for CAG as compared to tRNAs matching CAA (21 versus
11) and that the CAG codon abundance is almost 3-fold higher in human exons (Chan
and Lowe, 2009), but these numbers alone do not explain the 243-fold higher relative
amount of CAG repeats in human protein coding regions.
Similarly, we did a calculation for CTG repeats in the human genome, which, like
CAG repeats, are CG rich and when expanded are known to cause diseases of altered
RNA function (Gatchel and Zoghbi, 2005) such as Myotonic dystrophy type 1 (Miller
et al., 2000). Of a total of 136 CTG repeats, 7 were found in coding regions: 4 encoding
for polyL (CTG codon), 3 for polyA (GCT codon) and none for polyC (TGC codon).
As for CAG, the number of CTG repeats found in UTRs was significantly above random
expectation, suggesting that they also have a biological function in transcripts.
As CGG repeats have been previously described as being the most strongly overrepre-
sented trinucleotide repeats in human exons (Kozlowski et al., 2010), we also compared
their distribution in the human genome to that of CAG repeats. We observed a similar
distribution as the one for CAG and CTG with strong enrichment in UTRs and protein
coding exons. In summary, whereas CAG repeats are clearly selected because they code
polyQ in human proteins, there is some evidence of their function in non-coding parts of
transcripts. We observed this in other mammals and for other CG rich repeats expanded
in disease such as CTG.
5.3 Evolution of polyQ
After observing evidence for a function of CAG/glutamine repeats on protein level,
we next analyzed the phylogenetic distribution of polyQ in proteins. We determined
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the frequency of polyQ-containing proteins in a large number of species belonging to a
wide taxonomic range (Magrane and UniProt Consortium, 2011). For this analysis (and
hereafter, unless otherwise indicated), we identified as polyQ proteins those containing
at least one polyQ stretch with a minimum length of 10 glutamines allowing for one
mismatch (independent of its position within the polyQ tract) taking into account that
polyQ stretches are often interspersed with single amino acids. This is, for example, the
case in the known polyQ D. melanogaster Homeobox protein Deformed (positions 460
to 476: QQQAQQQQQSQQQQTQQ). The length threshold of 10 was chosen in order
to account for all nine known human polyQ disease proteins (Gatchel and Zoghbi, 2005).
Ataxin-7 is, among those disease proteins, the one with the minimum polyQ length of
10 residues in its non-expanded form. Using this definition, we found 86 human proteins
with a polyQ stretch in the manually curated subset of UniProt (Swiss-Prot) (Magrane
and UniProt Consortium, 2011).
We observed that the fraction of proteins having a polyQ stretch deviates greatly
among different species being practically absent from prokaryotes. Figure 5.2 displays
polyQ frequencies in several representative species from Swiss-Prot. This suggests that
the abundance of polyQ proteins is not a random feature but depends on properties that
vary between species.
To extend our analysis to an even broader taxonomic range we also calculated polyQ
frequencies in the entire UniProt database (which includes the automatically curated
sequences from TrEMBL). While the proteomes of bacteria and archaea typically contain
no proteins with polyQ tracts at all, lower and higher eukaryotes on an average have
0.1% proteins with polyQ tracts. The H. sapiens fraction of polyQ proteins is above the
average (0.34%) but much lower than that of many other organisms such as the yeast
S. cerevisiae (1.1%), the fly D. melanogaster (3.8%) or the slime mold D. discoideum
(10.5%).
5.3.1 PolyQ proteins in different organisms
In many cases, taxonomically related species have similar content of polyQ proteins but
this is by no means the rule. For example, one can observe extreme differences between
yeasts: the fission yeast Schizosaccharomyces pombe has only three polyQ proteins (out
of 4974, < 0.1%) whereas the baker’s yeast S. cerevisiae has 79 (out of 6552, 1.1%),
with other yeasts having even higher frequencies, e.g., Neurospora crassa (2.7%) and
Lodderomyces elongisporus (6.8%). Variation of polyQ protein content can be significant
even within species of the same genus. For example, in the 12 Drosophilae species that
were analyzed the fraction ranges from 2.7% in D. simulans to the 8.9% of D. grimshawi
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Figure 5.2: Relative amount of polyQ proteins in a representative set of
species. The graph represents the fraction of proteins of each species’ available proteome
that contains a polyQ tract. Species with more than 1000 proteins in Swiss-Prot were
included. Only two bacterial species are shown.
(median 4.2%). For the full list of polyQ abundance in species see Schaefer et al. (2012b).
Variation of polyQ protein content between species is generally high but we observed
that it is lower when we compare closely related species, suggesting that it is tied to
evolution. For example, while the three strains of the yeast Paracoccidioides brasiliensis
analyzed had slightly different numbers of proteins, their overall polyQ frequencies were
found to be similar (around 1.1%).
To find out whether there are species-specific functions that associated with polyQ
protein content, we studied the frequency of polyQ proteins in a species in relationship
to the presence of other proteins with particular domains. Protein domains are good
indicators of particular protein functions and subcellular locations. We calculated the
correlation between the relative number of proteins containing a polyQ stretch and the
relative number of proteins containing a given protein domain over species. For this
investigation, we used the protein annotations stored in the Pfam database version 23.0
(Finn et al., 2010), which hosts numerous accurate annotations of domains known or
predicted to be present in proteins.
We computed the correlations of 4088 domains found in human proteins over all bac-
terial and eukaryotic species with at least 5000 protein entries in Pfam (for a total of
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428 species, 133 of them eukaryotic and 295 bacterial). Since polyQ proteins are almost
absent from prokaryotes, many domains appeared to be correlated to polyQ protein
frequency mainly because they were exclusive to eukarya. Therefore, we additionally
computed the correlation on the eukaryotic subset and used this value as a second se-
lection criterion. We found 31 domains with a (Spearman) correlation value over all
species > 0.8 and a correlation value on eukaryotic species > 0.35 (Table 5.1) indicating
that these domains are generally enriched in the proteomes of species with many polyQ
proteins and are underrepresented in proteomes lacking polyQ.
Among the most highly correlated domains were the FYVE and the PX domains.
Remarkably, they are the only domains known to bind phosphatidylinositol 3-phosphate
(PI3P) (Stenmark et al., 2002). Version 6 of the SMART database of domain annotations
(Letunic et al., 2009) indicates that these domains do not co-occur in any of the current
set of annotated proteins. This suggests that the identification of these two domains
is based on independent sequences. The functional implication is that there is a true
association to polyQ proteins and, more precisely, that the presence of polyQ proteins
in a species is likely to be connected with processes that use PI3P, possibly in relation
to signaling and transport mechanisms in which this molecule is involved.
We can point to further striking functional and structural similarities between the 31
correlated domains supporting associations of polyQ proteins to particular functions.
Besides FYVE and PX, another three domains have a function in the phosphatidyli-
nositol (PI) signaling system: CRAL/TRIO, PH, and Phosphoinositide 3-kinase family
accessory domain. Two domains are related to ubiquitin (UBR box and UBX). Fi-
nally, we also observed five domains that belong to the zinc finger domain class: FYVE,
UBR box, Zinc-finger double-stranded RNA-binding, Zinc finger ZZ type, and HIT zinc
finger. Together, these observations suggest that polyQ proteins seem to be present in
high numbers in species rich in proteins with roles related to PI signaling and the protein
degradation system.
5.3.2 PolyQ emergence in protein families
Human non-pathogenic huntingtin contains an N-terminal polyQ tract of variable length
ranging from 11 to 34 glutamines (Gatchel and Zoghbi, 2005). Such N-terminal polyQ
appreciably and progressively shortens in orthologs from species increasingly distant
from human along the chordate lineage (Q10 in dog, Q7 in mouse, Q6 in opossum, Q4 in
Xenopus and fish; Figure 5.3, left box). We noted that the Drosophila huntingtin protein
in various Drosophilae does not contain any N-terminal polyQ stretch but has several
in two other regions of the protein (e.g., D. yakuba GenPept ID:195503512, has a Q10
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Domain Class Correlation oneukaryotic subset
Correlation on
all species
Importin-beta N-terminal domain 0.53 0.82
CAP-Gly domain 0.522 0.813
Zinc-finger double-stranded
RNA-binding ZF 0.494 0.823
Putative zinc finger in N-recognin
(UBR box) UBX, ZF 0.493 0.807
FYVE zinc finger PI, ZF 0.479 0.829
Ku70/Ku80 N-terminal alpha/beta
domain 0.476 0.806
GNS1/SUR4 family 0.47 0.8
Exportin 1-like protein 0.464 0.812
PX domain PI 0.447 0.826
Mitochondrial carrier protein 0.435 0.824
PH domain PI 0.432 0.817
Phosphoinositide 3-kinase family,
accessory domain (PIK domain) PI 0.431 0.803
Vps4 C terminal oligomerisation
domain 0.428 0.813
G-patch domain 0.423 0.82
Mitochondrial ribosomal protein L51
/ S25 / CI-B8 domain 0.417 0.818
RhoGAP domain 0.408 0.801
TBC domain 0.4 0.809
Domain of unknown function
(DUF3434) 0.397 0.806
LisH 0.396 0.815
CRAL/TRIO domain PI 0.393 0.814
La domain 0.393 0.802
MIF4G domain 0.391 0.803
GINS complex subunit Sld5 0.389 0.803
Region in Clathrin and VPS 0.382 0.819
UBX domain UBX 0.377 0.811
Calponin homology (CH) domain 0.375 0.819
Phosphotyrosyl phosphate activator
(PTPA) protein 0.37 0.807
emp24/gp25L/p24 family/GOLD 0.37 0.812
HIT zinc finger ZF 0.367 0.801
Zinc finger, ZZ type ZF 0.362 0.804
Vps51/Vps67 0.352 0.801
Table 5.1: Correlation of domains to polyQ presence over species. Structural
classes of the domains are indicated: zinc finger (ZF), ubiquitin (UBX) or phosphatidyli-
nositol (PI). Spearman’s rank correlation over 133 eukaryotic species and over the full
set of 428 species with high coverage in Pfam are given.
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Figure 5.3: Fragments of a multiple sequence alignment of huntingtin or-
thologs from several species. Glutamines and prolines are marked in red and green,
respectively. Left box: N-terminal polyQ region progressively enlarged along the chor-
date lineage and missing in Drosophilae. Note how this region is followed by polyproline
in some species where the polyQ length is above four. Right box: very variable polyQ
rich insertion specific to Drosophilae at another, distant position in huntingtin.
at positions 625-634 and a Q12 in a stretch of 14 amino acids at positions 1118-1131),
which have no equivalent in the human protein (Figure 5.3, right box). This indicates
that huntingtin proteins in ancestral species along the chordate and Drosophilae lineages
have experienced independent events of insertion of polyQ tracts. This would suggest
that the huntingtin protein is under evolutionary pressure to accept polyQ insertions,
but that this pressure would not seem to act on the precise position of those insertions
in the sequence.
To test whether this finding in huntingtin is unique or whether there are other pro-
tein families that underwent similar events during their evolution, we examined the
distribution of polyQ-containing proteins in families of proteins with members in human
(H. sapiens), zebrafish ((Danio rerio), representing another chordate) and the fly (D.
melanogaster, representing a non-chordate organism). Given a protein family, existence
of a polyQ in the human and fly proteins but not in the zebrafish protein will suggest
that at least two independent events of polyQ insertion occurred: one outside the Chor-
date lineage and another within the chordate lineage, after the divergence of zebrafish
and human.
We obtained 4759 protein families with at least one member from each of human, fly
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Figure 5.4: Protein families with multiple events of polyQ insertion. A total
of 4759 protein families with members in human, zebrafish and fly was studied. We
found 75 families having at least one human protein with a polyQ stretch, 354 families
having at least one fly protein with a polyQ stretch, and 4293 having no Q-rich region
in the fish proteins (see main text for details). For a total of 14 families (including
huntingtin), both the human and the fly sequences had polyQ tracts (red boxes within
the blue boxes) but not the zebrafish one, indicating multiple events of polyQ insertion
along separate lineages (stars). By randomizing the identity of the polyQ sets in human
and fly, we found the number of selected families to be significantly higher than random
expectation (p < 0.05).
and fish according to the database of phylogenetic trees TreeFam (Ruan et al., 2008).
We then selected those families in which the more distantly related species (human and
fly) both had at least one homolog with a polyQ stretch (here requiring 8 Q in a range
of 10 residues) while the zebrafish homologues were required to have no polyQ stretch
at all (less than 5 Q in a window of size 10), considering them as families with evidence
of multiple evolutionary events of polyQ insertion (see Figure 5.4). A total of 14 protein
families fulfilled this conservative criterion. This number was significant (p < 0.05,
randomization test). Considering also that in most cases the polyQ stretches appear at
different protein positions within the aligned protein family, we conclude that the most
likely explanation for the distribution of polyQ regions in the protein families analyzed
is that polyQ emerged independently at different time points during evolution rather
than that being lost in zebrafish.
The emergence of a significant number of protein families where insertion of polyQ
tracts occurs in multiple ancestral proteins suggests that functional selection for the
insertion of polyQ tracts at the protein level is a significant factor affecting the evolution
of polyQ tracts. The fact that these insertions may be located at different positions in
the protein suggests that polyQ performs a function that is not bound to a particular
sequence. Insertion of polyQ tracts, however, does not seem to be absolutely necessary
and therefore its function, while advantageous, must depend on some pre-existing, more
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Category HS BT RN MM DR DM CE AT SC DD NC
Transcription-related X X X X X X X X X
Nucleus X X X X X X X X X
(RNA and nitrogen) metabolic
or biosynthetic process
X X X X X X X X
Compositionally biased region
(Ser,Gly,Pro,Ala)
X X X X X X
Protein phoshporylation X X X X X
Alternative splicing X X X X
Protein dimerization activity X X X
Developmental protein X X X
Table 5.2: Frequently overrepresented functional annotations among polyQ
proteins from 11 eukaryotic species. HS = H. sapiens, BT = B. taurus, RN =
R. norvegicus, MM = M. musculus, DR = D. rerio, DM = D. melanogaster, CE =
C. elegans, AT = A. thaliana, SC = S. cerevisiae, DD = D. discoideum, NC = N.
crassa. We merged the resulting species-specific lists of functional terms (applying a
p-value threshold of 0.05 after multiple testing correction with the Benjamini-Hochberg
method) and replaced similar terms by representative substitutes.
important functional context.
5.4 Protein context of polyQ
5.4.1 Function of polyQ proteins
It has already been noted that polyQ proteins are biased toward functions related to
transcriptional regulation and nuclear localization (Alba and Guigo, 2004; Harrison,
2006; Karlin and Burge, 1996). To make a comprehensive analysis of the association
of polyQ function to particular functions in the proteins containing it, we collected the
polyQ proteins from 11 eukaryotic organisms of different taxa including plants, fungi,
nematodes and chordates. We selected species with a sufficiently large coverage of the
manually curated subset of UniProt (we required >750 protein entries in Swiss-Prot) and
a minimum number of eight polyQ proteins to allow for conclusive enrichment statistics.
From the resulting list we removed two of the three yeast members (Kluyveromyces
lactis and Candida albicans) to end up with a diverse, representative set of eukaryotic
species: H. sapiens, B. taurus, R. norvegicus, M. musculus, D. rerio, D. melanogaster,
C. elegans, Arabidopsis thaliana, S. cerevisiae, D. discoideum and N. crassa. We then
studied their functional annotations using two complementary approaches.
First, we computed the enrichment in GO annotations associated to these polyQ sets
with respect to the total protein set. We analyzed each of the 11 species independently
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using the web tool DAVID (Dennis et al., 2003). Annotations significantly enriched
in the polyQ sets of several of these species included nuclear-related functions (e.g.,
transcription, splicing), but interestingly also protein dimerization, which correlates with
our previously discussed findings suggesting that polyQ is involved in protein interactions
(Table 5.2).
Second, we evaluated the enrichment of domains given by Pfam version 23.0; (Finn
et al., 2010). A total of 14 domains were significantly overrepresented in polyQ proteins
in at least 3 out of the 11 species (with corrected p < 0.05; see Table 5.3). However, we
did not find these domains to be located closer than randomly expected to the polyQ or
even overlapping the polyQ stretches.
Overall, most of these domains group into five functional categories: transcription
regulation, protein binding, chromatin maintenance, RNA binding and signaling. For
example, we found that more than a third of the domains enriched in the polyQ sets of at
least three species are involved in protein-protein interactions (PAS fold, Bromodomain,
PHD finger, PH, PDZ). Many of the associated domains fulfill functions in the nucleus.
In agreement with the association of polyQ protein content to PI signaling that we
found at genomic level, we observed the PH domain, which is related to this function,
to be enriched in the polyQ sets of three species. Many PH domains bind PI (10-20%),
while others bind lipids, as well as peptides and proteins (DiNitto and Lambright, 2006).
5.4.2 Sequence features of polyQ flanking regions
The sequence environment of polyQ regions has been observed to influence the aggre-
gation properties of polyQ-containing proteins, particularly polyproline (polyP) tracts
(Bhattacharyya et al., 2006). In order to study the sequences surrounding polyQ for
amino acid biases other than glutamine, we determined frequencies of amino acids in
and around polyQ stretches in human proteins.
We found proline, histidine, alanine and methionine to be the four most strongly en-
riched amino acids around polyQ stretches in human proteins while cysteine, tryptophan,
aspartic acid and isoleucine were the most under-represented (Figure 5.5). Analysis of
other species revealed that the enrichment of proline and histidine in proximity of polyQ
was conserved in S. cerevisiae, D. melanogaster and D. discoideum. We could not iden-
tify general amino acid properties (e.g., large size, high hydrophobicity) common to the
amino acids in the under- and over-represented sets.
The described amino acid bias is not evenly distributed to both sides of the polyQ
stretch. In human sequences the most extreme case is found for prolines, which often
appear as polyP tracts almost exclusively C-terminal of the polyQ. For example, in the
60
5 Evolution and function of polyglutamine in protein-protein interaction networks
Domain HS BT RN MM DR DM CE AT SC DD NC
PHD-finger X X X X X X X
Bromodomain X X X X X X X
Helix-loop-helix DNA-binding
domain
X X X X X X
RNA recognition motif. X X X X X
Homeobox domain X X X X X
PAS fold X X X X X
Helicase conserved C-terminal
domain
X X X X
Protein tyrosine kinase X X X X
Protein kinase domain X X X X
PDZ domain X X X
PH domain X X X
Zinc finger, C2H2 type X X X
ARID/BRIGHT DNA binding
domain
X X X
SNF2 family N-terminal domain X X X
Table 5.3: Domains overrepresented in polyQ proteins from eleven eukaryotic
species. HS = H. sapiens, BT = B. taurus, RN = R. norvegicus, MM = M. musculus,
DR = D. rerio, DM = D. melanogaster, CE = C. elegans, AT = A. thaliana, SC = S.
cerevisiae, DD = D. discoideum, NC = N. crassa.
Figure 5.5: Amino acid usage in flanking sequences of polyQ. Amino acid usage
in human proteins was calculated for polyQ stretches and for the 50 amino acids flanking
polyQ. The y-axis represents the log of the ratio of the frequency of the amino acid in
the flanking sequence to the frequency of the amino acid in the human genome.
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set of 86 human polyQ proteins, 13 proteins contain a polyP run of at least three residues
at a maximum distance of three amino acids from the polyQ. Of those we found twelve
C-terminal and only one N-terminal to the polyQ stretch. This agrees with the findings
of Bhattacharyya et al. (2006) that polyP stretches inhibit polyQ-dependent aggregate
formation only when located C-terminal of the polyQ tract. The other enriched amino
acids (alanine, methionine, histidine) tend to occur as single amino acid residues and
the number of repeated amino acid tracts surrounding polyQ was too small to assess
any distributional bias.
In a recent computational study polyQ tracts were associated with the presence of
disordered regions (Simon and Hancock, 2009). To quantify this association, we applied
the stand-alone version of the tool RONN (Yang et al., 2005) for the prediction of
disordered regions. We considered residues with a probability above 0.8 to be disordered.
We found 96 regions predicted as disordered at a distance of 10 or less residues from
polyQ tracts in human proteins, which affects the vast majority of all 109 polyQ stretches.
To test whether this finding is due to the polyQ tract itself being predicted as disordered,
we repeated the computation, this time removing the corresponding polyQ tracts from
the sequence. From the 96 regions, 35 remain disordered after polyQ tract removal. To
assess the significance of this observation, we calculated estimates of the background
frequency of disordered regions among all human proteins by randomly sampling 1000
human proteins from the Swiss-Prot database and determining the proportion of residues
predicted to be disordered among all residues within the sample. The enrichment of
disordered regions around polyQ deletion sites was significant (p = 6.2e-11).
5.5 PolyQ in PPI networks
5.5.1 PolyQ in protein complexes
Both, previous studies (Hands et al., 2008) as well as the above described functional
association of the polyQ set to protein dimerization, indicate an involvement of polyQ in
PPIs. To look for further evidence supporting this hypothesis, we investigated whether
polyQ-containing proteins are enriched among proteins that form complexes. Among
1825 human protein complexes defined in Ruepp et al. (2008), we identified 130 having
at least one protein containing a polyQ stretch (using the same polyQ definition as
above: repeat length of 10 glutamines allowing for one mismatch).
These 1825 human complexes are formed by 8797 components; among them 149 are
polyQ proteins, showing a 4-fold enrichment with respect to the frequency of polyQ
proteins in the human proteome. In the non-redundant list of 2541 proteins participating
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in complexes, the enrichment is still significant (2.1-fold). This suggests that polyQ
proteins even have a tendency to form part of multiple complexes. Examples of human
polyQ proteins that are members of several complexes are CBP and TBP.
To test whether there is a significant tendency to find multiple polyQ proteins within
individual protein complexes, we applied a randomization test. We randomized the
polyQ annotations and observed whether we obtained an equal or larger amount of
complexes containing two or more polyQ proteins, which happened in 52 of 1000 tests
(p = 0.052). For less restrictive polyQ threshold selections, the results were even more
significant (e.g., eight Qs in a window of 10 residues resulted in p < 0.001). This
suggested that polyQ-containing proteins are not randomly distributed among complexes
but that the chance of seeing one polyQ protein increases significantly the chance of
finding at least one other polyQ-containing protein in the same protein complex. For
example, the RSmad complex contains a total of 10 proteins. Among them are three
polyQ-containing proteins: ARID1B, CBP and NCOA3. In summary, protein complexes
are enriched in polyQ proteins suggesting that polyQ function is related to protein
interactions.
5.5.2 PolyQ tracts are associated to proteins with many partners
To further investigate the association of polyQ with protein interactions, we compared
the distribution of polyQ-containing proteins and the number of protein interacting
partners (according to the HIPPIE database of human PPI data described in Chapter 3).
We observed that proteins containing polyQ have significantly more interactions than
proteins that do not (p < 10−9, Wilcoxon-Mann-Whitney test). However, we observed
that polyQ proteins have a longer than average length (1253 residues versus 550 residues)
and that longer proteins have more interaction partners as compared to short proteins,
probably due to their higher number of potential interaction interfaces (e.g., the longest
25% of all human proteins have a mean value of 9.1 interaction partners while the
shortest 25% have only 4.9). Therefore, we repeated the test comparing the polyQ set
with proteins at least as long as the average polyQ-containing protein. The resulting
p-value of 0.007 indicated a higher number of interaction partners for the polyQ set.
Since it is likely that transcription factors have more interactions than the average
protein and polyQ proteins are enriched in transcription factors, we repeated the test
comparing the interaction distribution of the polyQ proteins to that of the set of human
transcription factors as defined by UniProt annotations (Magrane and UniProt Consor-
tium, 2011) without a polyQ tract (Figure 5.6A). The resulting p-value of 0.009 was
once again significant.
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Figure 5.6: Protein interaction degree distribution for different classes of
proteins. Box plots of the distribution of protein interaction partners for different
protein sets. (A and B) Comparison of polyQ proteins, transcription factors without
polyQ, large proteins without polyQ and all non-polyQ proteins, for human and yeast,
respectively. All pairwise differences within a species were significant (p < 0.01).
As we have shown in Chapter 3, PPI networks are highly biased by the experimental
selection of bait proteins. As a consequence, the measured number of interaction partners
of a protein depends not only on its true physiological number of interactions but also on
how intensively the protein has been studied in PPI assays. Since several polyQ proteins
known as disease-causing agents have been studied multiple times, we assume that this
could have an impact on the amount of reported interactions of polyQ proteins. Indeed,
when comparing the bait usage numbers within the polyQ set with those in the entire
proteomic background, we find a higher fraction of polyQ proteins that have been used
several times as a bait (24.4%) than among the non-polyQ proteins (6.7%). To rule out
the possibility that the observed higher number of interactions formed by polyQ proteins
is solely due to the selection bias, we chose two strategies to control for the higher bait
usage frequencies among polyQ proteins: (a) we repeated our analysis in another species
in which we do not expect a study bias towards polyQ proteins and (b) compared the
mean number of interaction partners of polyQ proteins to randomly sampled sets with
the same bait usage distribution.
We carried out the analysis with the proteins of S. cerevisiae (BioGRID v3.1.74; Stark
et al. (2011)) and observed that its polyQ proteins have a significantly higher number
of interacting partners than those that do not have polyQ (p < 10−12), even when
filtering for transcription factors (p = 0.041) or proteins of higher length (p = 0.0003)
(Figure 5.6B). These results confirm that our findings are not species-specific and suggest
that our observations in human proteins are not due to a bias in the PPI network arising
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Figure 5.7: Mean interaction number of proteins with same bait usage dis-
tribution as polyQ set. We find the number of observed interactions of the polyQ set
significantly larger.
from researchers focusing on particular human proteins related to disease.
To directly control for the high fraction of polyQ proteins that have been screened
several times for interaction partners, we randomly generated sets of proteins where
polyQ proteins that have been studied multiple times have been replaced by non-polyQ
proteins which have been used the same number of times as a bait protein. For each of
the 10,000 generated random sets, we calculated the mean number of interaction partners
(Figure 5.7) and found the observed mean value for the polyQ set significantly larger
(p = 0.028). We repeated the comparison requiring the randomly sampled proteins to
be transcription factors and having a similar length as polyQ-containing proteins and
found both distributions of mean number of interaction partners significantly lower than
the observed value for the polyQ set (p < 0.05).
To test whether there is an effect of the length of the polyQ stretch on the number of
interactions, we binned either all human or all yeast proteins into the three categories:
lacking polyQ tract, having a small polyQ stretch (length between 5 and 14 amino
acids), and having a long polyQ tract (longer than 14 amino acids). As in the analyses
described earlier, we counted the number of interactors for each of these proteins (Fig-
ure 5.8). The differences between the degree distributions were significant (p < 0.01)
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Figure 5.8: Protein interaction degree distribution for different lengths of
polyQ. Box plots of the distribution of protein interaction partners for different protein
sets. (A and B) Comparison of proteins with long polyQ, short polyQ, or no polyQ, for
human and yeast, respectively. All pairwise differences within a species were significant
(p = 0.01) except for the comparison between medium and long polyQ length in yeast
(p = 0.056). This exception was due to an outlier in the medium set: one of the proteins
has a degree of 2549 which is more than twice as high as the second highest degree.
Removing it results in significant differences for all comparisons.
and increased with the length of the polyQ tract both for human and for yeast proteins.
This observation suggests a correlation between the length of polyQ and the interaction
capacity of the hosting protein.
In summary, these analyses demonstrate that polyQ proteins have more protein in-
teractions than proteins lacking a polyQ tract. Although there is a component in that
effect related to polyQ proteins having longer than average length, being associated to
particular functions and being used as baits more often than other proteins, these prop-
erties of polyQ proteins alone are not responsible for the whole effect. We interpret these
results as indicating that polyQ tracts favor PPIs.
5.5.3 Function of proteins interacting with polyQ proteins
We found that polyQ proteins are associated with interactions between proteins and
that polyQ proteins are enriched in some general functions related to the nucleus such
as transcriptional regulation and chromatin maintenance among others. We wondered
whether there would be particular domains or functions specific to the proteins interact-
ing with polyQ proteins. These would account for other indirect functional associations
of polyQ proteins.
To investigate this, we measured the significance of over-representation of predicted
domains in non-polyQ proteins that interact with polyQ proteins. To detect overrep-
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resented domains in the set of proteins interacting with the polyQ proteins in the PPI
network, a randomization test was applied. As a test statistic, the number of interac-
tions between either the polyQ or the random set, and the domain set was calculated.
The background distribution was generated by selecting a set of non-polyQ proteins,
preserving the degree distribution and the fraction of transcription factors of the polyQ
set.
In our analysis of proteins interacting with polyQ proteins, we found 17 domains
significantly enriched (occurring in more than 10 polyQ-protein interacting proteins;
p < 0.01). The list of domains was manually curated to remove redundant entries
and obvious false positive predictions (as detailed in Schaefer et al. (2012b)). The set
was different from the set of domains found to be enriched in polyQ proteins with the
exception of nuclear hormone receptor domains (NHR and Zinc finger C4 type). In
general functional terms, the list of domains once again contained an important fraction
of domains with nuclear functions (NHR, bZIP, MH1, Zinc finger MIZ type). However,
it also included domains with non-nuclear functions (Ubiquitin family, AAA, EGF). The
curated set of domains enriched in proteins interacting with the polyQ set is listed in
Table 5.4.
For comparison, we tested the enrichment of protein domains in proteins interacting
with polyP tracts (defined as for polyQ tracts: minimum number of 10 consecutive
P allowing for one mismatch). The known polyP interacting domains SH3 and WW
were among the top 15 most enriched domains (additionally, Actin, RhoGEF, SH2,
BAR, Spectrin, Arf, FF, PX, FCH, WH1, CH, RhoGAP and the UBX domain) all
being significantly associated to polyP (p < 0.01). The strength of these associations is
comparable to that of the top polyQ associated domains.
5.5.4 PolyQ as a motif for protein interaction
Multiple observations presented above seem to indicate that polyQ is involved in PPI:
polyQ proteins are related to dimerization, proteins with longer polyQ tracts tend to
have more interaction partners, and many human protein complexes contain multiple
polyQ proteins.
In addition, among the 86 human polyQ-containing proteins, we counted 49 interac-
tions where both interacting proteins contained polyQ tracts. Randomizing the identity
of the polyQ set, we found this enrichment as significant as the enrichment determined
for domains present in proteins interacting with polyQ proteins (p = 0.0023).
Moreover, among the list of domains enriched in proteins that interact with human
polyQ proteins, we observed the bZIP domain, which can form a coiled-coil. It was
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Domain P-value Number
interactions
Nuclear hormone receptor associated < 0.001 95
EGF < 0.001 29
ATPase family associated with various
cellular activities (AAA) < 0.001 24
Zinc finger MIZ type 0.002 12
Ubiquitin family 0.002 25
MH1 domain 0.007 30
Basic Leucine Zipper Domain (bZIP) 0.009 37
Table 5.4: Domains overrepresented in proteins that interact with human
polyQ proteins.
recently shown that polyQ regions overlap with coiled-coil regions in a set of polyQ-
containing proteins and are also found in their interaction partners (Fiumara et al.,
2010). Coiled-coil domains are involved in oligomerization. This would explain the
function of polyQ observed above as a ubiquitously used motif of protein interaction.
To determine whether the association of polyQ tracts and coiled-coil regions is a
general phenomenon, we systematically studied the overlap between polyQ regions and
predicted coiled-coil regions in polyQ proteins. For the prediction of coiled-coils, we
applied the tool Coils (Lupas et al., 1991), which detects hydrophobic heptad repeats in
protein sequences. We considered only high-confidence predictions (over a probability
threshold of 0.8). We observed a significant enrichment in human and in the other 10
eukaryotic species analyzed (we studied the same set of representative species as used
in section 5.4.1). For example, of the 109 polyQ tracts in 86 human proteins, 54 (50%)
overlapped with a coiled-coil region and 5 more were in very close proximity (distance
of 10 amino acids or less) (p < 10−15).
We found that the distribution of coiled-coils is extremely biased toward the N-
terminus of the polyQ tract. In this respect, one has to note that the amino acid
composition of the regions surrounding polyQ tracts is biased for some amino acids. As
described in section 5.4.2, we could detect enrichment for several amino acids around
polyQ tracts in several organisms and the described amino acid bias is not evenly dis-
tributed to both sides of the polyQ stretch. In human sequences, proline is most strongly
enriched and often appears as a polyP tract C-terminally to the polyQ.
To exclude the possibility that the bias of coiled-coils toward the N-terminus of polyQ
tracts is simply due to C-terminal polyP, we analyzed the position of coiled-coils with
respect to polyQ tracts excluding cases where polyP was present. The bias was still
68
5 Evolution and function of polyglutamine in protein-protein interaction networks
observed both in human (34 N-terminal versus 6 C-terminal) and yeast (14 N-terminal
versus 1 C-terminal), suggesting that the association of coiled-coils to polyQ tracts is
asymmetric.
To exclude the possibility that the observed colocalization of coiled-coils with polyQ
stretches is an artifact of the prediction tool that was applied (e.g., over-predicting
spurious coiled-coil regions on polyQ stretches), we repeated the coiled-coil prediction
on the human polyQ set with a different coiled-coil prediction approach using the tool
Paircoil2 (McDonnell et al., 2006). We found, again, a significant enrichment of coiled-
coils in the polyQ set: for a tool specific threshold of 0.025, we observed 30 proteins with
a coiled-coil among the 86 human polyQ proteins (34.9%) at a background prediction
rate of 13% (p < 10−9).
To further substantiate our observations, we deleted the polyQ stretches from the
sequences and repeated the coiled-coil prediction in 45 human proteins hosting 54 polyQ
stretches that were either overlapping a coiled-coil or in close proximity of one. We
excluded from this analysis those proteins where the coiled-coil was predicted to be
within a polyQ stretch and those with a C-terminal polyP. We counted how often we
could still observe a coiled-coil prediction in the 10 residues flanking each side of the
54 deletion sites. In 11 of the 54 cases, a coiled-coil was predicted, which corresponds
to a 6-fold enrichment over the background frequency of predicted coiled-coil regions in
all human protein sequences. This enrichment was significant (p < 10−6; probability of
observing 11 or more coiled-coil regions under the Binomial distribution). This result
proves that the association of polyQ to coiled-coil regions is not just due to the presence
of polyQ but that also its flanking sequences have significant coiled-coil forming potential.
In addition to the enrichment of coiled-coils in proteins with a polyQ stretch, we could
also establish that non-polyQ proteins interacting with polyQ proteins are significantly
enriched in coiled-coil regions (p < 0.001).
In summary, we found a significant association of polyQ tracts after coiled-coil regions.
This agrees with a function of polyQ tracts related to protein interactions. We wondered
if functions previously noted to be associated to polyQ proteins (Alba and Guigo, 2004;
Harrison, 2006; Karlin and Burge, 1996) could be just a secondary effect and explained
simply by the fact that those functions (e.g., transcriptional regulation) require more
protein interactions than other functions (e.g., metabolism). Therefore, we tested if we
observed a similarly high enrichment in certain GO terms when we compared proteins
with many interactions to all proteins with at least one known interaction. Indeed, many
functions associated to the polyQ set are also enriched in the set of proteins with the
10% highest number of interaction partners. For example, both in yeast and human,
69
5 Evolution and function of polyglutamine in protein-protein interaction networks
we observed in the set of proteins with many partners a significant enrichment of the
GO term GO:0031981-nuclear lumen (p-values of 6.3e-53 and 4.2e-28) and in human
proteins of the term GO:0008134-transcription factor binding (p < 10−23). This effect
is independent of the precise protein set size and can be reproduced with the 86 highest
degree proteins in human (a cutoff chosen in accordance with the size of the human
polyQ set).
5.6 Discussion
PolyQ tracts in protein sequences have been researched mostly because of their patho-
genic expansion in multiple human genetic diseases. However, their presence in many
wild-type proteins across a variety of species is intriguing and suggests that normal
polyQ tracts might have a function.
Following this idea, we provided evidence collected at multiple inter-related biological
levels that collectively and consistently indicates that polyQ tracts are involved in protein
interactions, e.g., because of their enrichment in protein complexes, and their association
with coiled-coil regions. Through our analyses, we noted other features of polyQ tracts,
which may not be directly related to their function as an interaction motif, but to the
pathogenic effects of their abnormal expansion.
At the nucleotide level, we could observe selection of CAG repeats in exons of human,
mouse, rat and fly genes. Intriguingly, we also found them enriched, although at a lower
level, in UTRs. It was noted that both CAG and CTG repeats can form RNA-DNA
hybrids (R loops) that could have a biological function (Lin et al., 2010; Reddy et al.,
2011). In agreement with this, we found CTG and CGG repeats similarly enriched in
UTRs but not so much in exons.
Along these lines, we found that whereas only 13% of prolines in human proteins are
encoded by the rare codon CCG, this fraction is higher in prolines forming polyP (of
length three or more) (23%), and even higher (43%; n = 48 codons) if the polyP is
near uninterrupted polyQ sequences of minimum length 10 (at a maximum distance of
three amino acids). We observed a related effect in polyQ, which are encoded more
frequently by CAG codons when the polyQ sequences are close to polyP tracts (n =
156) as compared to other polyQ (n = 1169) (90% versus 79%). This inter-dependence
between GC rich codons hints at an effect at the transcript level. In summary, we
interpret these results as indicating that CAG repeats are under positive selection at
the nucleotide level. Abnormally expanded CTG repeats bind muscleblind resulting in
Myotonic dystrophy type 1 (Miller et al., 2000). CAG and CTG repeats might bind to
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proteins in their wild-type transcripts.
The mechanisms that have been proposed to originate regions encoding poly-amino
acid repeats are currently not well understood (Kovtun and McMurray, 2008). Many
polyQ tracts are composed exclusively of CAG repeats in mammals (Alba et al., 2001)
(the other possible codon encoding Q being CAA); this is interpreted as evidence of their
formation due to trinucleotide expansion by gene slippage, resulting from the formation
of an abnormal loop of the CAG repeat via CG pairings. According to this, it was shown
that polyQ-coding pure CAG repeats are expanded from mouse to human (Hancock,
1995) while expansion does not occur if they are formed by a mix of CAG and CAA
codons. In contrast, in some non-mammalian organisms, for example Drosophila (Alba
et al., 2001) and D. discoideum (Eichinger et al., 2005), polyQ tracts tend to be encoded
by pure CAA repeats actually suggesting that they are selected to resist slippage.
The abundance of proteins with polyQ tracts across different species is highly variable,
for example they are completely absent from prokaryotic organisms. In a few species,
polyQ tracts are among the most frequent amino acid repeats (Faux et al., 2005; Karlin
et al., 2002). This variability may be related to the inability of some species to deal with
these aggregation-prone repeats. Therefore, analysis of the correlation between systemic
properties of species and presence of polyQ proteins might hint at the mechanisms by
which species deal with polyQ proteins and at the origin of their pathogenic effects. We
investigated this systematically and observed a huge variation between species in content
of polyQ proteins (e.g., highest in D. discoideum and D. melanogaster but very low for
Xenopus or D. rerio). We observed that those species with high polyQ protein content
have a higher number of proteins bearing domains with functions related to PI signaling
and ubiquitin-directed protein degradation. Interestingly, both ubiquitin and PI play
a role in the clearance of polyQ aggregates: aggregates containing proteins with an
expanded polyQ stretch have been shown to be ubiquitinated (Suhr et al., 2001a), while
PI-binding domains are involved in targeting polyQ aggregates to membranes during
the process of macroautophagy. For example, the FYVE domain containing human
protein Alfy promotes the degradation of huntingtin in mammalian cells (Filimonenko
et al., 2010). Therefore, this association between high content of polyQ proteins at the
genomic level to both PI signaling and ubiquitin-directed protein degradation could be
explained by the need of the cell to effectively degrade polyQ-containing aggregation-
prone proteins. We speculate that differential selection explains the high content of
polyQ proteins in some organisms (Hancock, 1995): organisms that can select polyQ co-
evolve the appropriate machinery to clear polyQ protein aggregates, whereas organisms
lacking strong clearance mechanisms for protein-aggregates might not tolerate polyQ
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proteins at all; this could explain the absence of polyQ proteins in the prokaryotes.
When analyzing the variability of polyQ protein occurrence in a large variety of species
in more detail, we observed that polyQ tracts are not a feature characteristic of particular
gene families. Variability of polyQ protein content among species is therefore due to
orthologs of a protein having a polyQ tract in one species and not in another. Moreover,
we demonstrated that particular protein families show multiple events of emergence of
polyQ and that they can happen at different positions of the sequence. For example,
the human huntingtin has a polyQ tract situated near the N-terminus of the protein,
whereas many lower organisms have none, e.g., Ciona (Gissi et al., 2006). However,
the huntingtin of the Drosophila genus has multiple polyQ tracts, none of them in the
N-terminus. This suggests that particular protein families, including huntingtin, are
under selective pressure to accumulate polyQ tracts. In summary, the fact that some
organisms have orthologs lacking the polyQ tract indicates that the protein can fulfill
its tasks without this feature: its function cannot be essential. In addition, the fact
that the polyQ tracts can occupy different positions in the sequence suggests that polyQ
tracts perform a function without strong positional requirements. On the other hand,
they do have some function specific to particular protein families since evolutionary
pressure to insert the polyQ tracts leads to this occurring in distantly related clades.
In terms of speed, the evolutionary expansion of a polyQ tract is much slower than a
pathological expansion. For example, the expansion of the N-terminal polyQ tract in
human huntingtin could be estimated to have evolved at an average rate of one Q per
30 million years. This is indicative of how delicate the effect of modification of polyQ
tract length can be (Figure 5.3, left box). On the other hand, the large variations of the
huntingtin mid-of-sequence polyQ tracts in the different Drosophilae indicate that fast
evolution of polyQ tracts is also possible (Figure 5.3, right box).
There is already some experimental evidence suggesting that the function of polyQ
could be to modulate PPIs. For example, a polyQ sequence in TBP modulates its
interaction with TFIIB (Friedman et al., 2007), and a glutamine-rich activation domain
in SP1 directly interacts with TAF4 in Drosophila (Hoey et al., 1993). It was observed
in an in vitro experiment that mouse Sp1 and some components of the core transcription
apparatus (e.g., TFIID and TFIIF) are direct targets inhibited by mutant huntingtin
in a polyQ-dependent manner (Zhai et al., 2005). In addition, mutant proteins with
enlarged polyQ tracts aggregate, which also points to a relation between polyQ and
protein interactions (Kopito, 2000; Ross, 1997; Tran and Miller, 1999).
We were able to provide further evidence at multiple levels to support the hypothesis
that polyQ modulates PPIs. For example, we could detect that polyQ proteins have
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more protein interaction partners than non-polyQ proteins and have a higher tendency
to interact with other polyQ proteins than non-polyQ proteins.
In agreement to previous studies (Whan et al., 2010), we identified an over-represen-
tation of protein domains related to nucleus-based functions in polyQ proteins but also
in proteins that interact with them. In fact, we could demonstrate that these functions
are also over-represented in proteins with many interactions. Therefore, we deduce that
the functional biases observed in polyQ and polyQ-interacting proteins are due to the
involvement of polyQ in protein interactions.
Until now, the structural basis for the possible modulation of protein interactions by
polyQ is not clear. To begin with, the precise structure of polyQ itself is unknown and
suggested conformations of both synthetic polyQ peptides and naturally occurring pro-
teins with polyQ tracts include alpha helix, random coil, and extended loop as it has
been described for huntingtin exon1 (Kim et al., 2009; Li et al., 2007). This might be
due to polyQ adopting an unstable context-dependent structure. Part of this context
can be flanking sequences, which have been shown to influence both the structure (Kim
et al., 2009) and aggregation properties of polypeptides with polyQ tracts (Dehay and
Bertolotti, 2006). Length expansions of polyQ stretches seem to be accompanied by
a transition of a random coil into a beta sheet structure (Perutz, 1996), which would
account for its pathogenic effect. In addition, polyQ tracts seem to be able to mod-
ify the conformation of structured domains nearby in sequence (Ignatova and Gierasch,
2006). Such interactions could be dependent on the presence of other interacting pro-
teins, and it has recently been suggested that the mechanisms by which polyQ modulate
protein interactions might be the expansion of sequence-adjacent coiled-coil regions upon
interaction of the coiled-coil region with another protein (Fiumara et al., 2010).
In support of this view, we found a strong association between polyQ and coiled-coil
regions: both are found in the same sequence more often than random expectation, over-
lapping or at very short distance, as well as in proteins that interact with each other.
This association was more significant than the association of polyQ to any protein do-
main. This includes the association to disordered regions (Simon and Hancock, 2009)
that was weaker than the one found for coiled-coil regions (3.3-fold versus 6-fold enrich-
ment in proximity of polyQ). In summary, our results indicate that polyQ expansions
are selected in evolution to extend coiled-coil regions that take part in protein-protein
interactions.
We found a strong bias for coiled-coil regions to be situated N-terminally of polyQ
tracts. At the same time, polyP is sometimes found near polyQ and if so, often C-
terminally to the polyQ tract. This is in agreement with the finding that polyP stabilizes
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the structure of adjacent polyQ when located C-terminally but not when located N-
terminally of it (Bhattacharyya et al., 2006). In an X-ray study of huntingtin exon 1,
having polyP C-terminally adjacent to polyQ, the polyP was found to adopt a classical
left-handed poly-proline helix structure (Kim et al., 2009). In synthetic polyQ peptides
polyP fused to the C-terminus was shown to force polyQ into such a helical structure as
well (Darnell et al., 2007). The property of proline to influence conformation is known
in contexts other than polyQ proteins (Williams et al., 2004; Wood et al., 1995).
The second most frequent amino acid we observed enriched in proximity of polyQ
was histidine. Several studies reported a protective role for histidine, similar to that of
proline, preventing aggregation of polyQ stretches (Jayaraman et al., 2009; Sen et al.,
2003). We find it interesting to note that the third most strongly enriched amino acid
in and around polyQ, alanine, is often found in the hydrophobic interface of coiled-coils
(Gromiha and Parry, 2004).
According to this evidence, we propose that polyQ tracts have a tendency to follow
a coiled-coil region that they expand upon protein interaction. The conformational
extension by polyQ of the coiled-coil region is then stabilized and paused by a capping
sequence which, like polyP, acts directionally to stabilize and stop the growth of the
helical region (Figure 5.9).
In summary, our results lead to the following general picture of the function of polyQ:
its activity as a motif for protein interaction is tightly related to the length of the polyQ
tract itself, the character of the sequences adjacent to it and to the concentration of
interacting protein partners. We assume that the normal interplay of all these elements
would lead to an enhanced, highly stable and specific interaction. However, the com-
plexity of this system also suggests that small perturbations could lead to pathological
interactions either with altered affinities or with different partners. The complex inter-
action of factors influencing the function of polyQ tracts perhaps explains why so many
processes have been found to contribute to the pathomechanism of polyQ diseases includ-
ing transcriptional dysregulation (Truant et al., 2007), RNA toxicity (Li et al., 2008),
impairment of the ubiquitin-proteasome system (Bence et al., 2001; Chai et al., 1999;
Waelter et al., 2001), mitochondrial dysfunction (Lin and Beal, 2006) and disturbed
calcium signaling (Tang et al., 2005).
Our results also suggest that a given species may accumulate an abundance of polyQ
proteins to modulate many protein interactions. However, this may come at no small
expense: protein networks with abundant polyQ proteins may be in a delicate balance
in which aggregation can occur depending on the concentration of many molecules. This
balance might be lost in specific tissues and circumstances as mechanisms to keep protein
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Figure 5.9: Cartoon of proposed polyQ function in protein interaction. Left:
a polyQ protein contains a coiled-coil (blue), followed by a polyQ region (red) and
a polyP region (green). In the unbound state, the polyQ region is disordered. Right:
upon interaction with a protein partner X, the polyQ region adopts a coiled-coil structure
that extends the original coiled-coil. The polyP region remains unstructured capping
precisely the extension of the coiled-coil.
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aggregates in check get challenged in ageing cells, as it has been observed in C. elegans
(David et al., 2010). This may explain why neurons of the elderly are particular prone
to anomalous polyQ expansion and in turn neurodegeneration.
We suggest that the study of the function of wild-type and pathogenic polyQ proteins
will require experiments to test the variation in functionality that removing or expanding
particular polyQ stretches will produce. Specifically, it needs to be investigated how these
modifications influence the interaction abilities of the polyQ protein. Special attention
should be paid to the gain or loss of interactions of other proteins with coiled-coil regions
and polyQ. Explaining and predicting the effects of polyQ tracts will require elaborate
analysis for each particular situation. The recent analysis of SCA1, where dramatic
differences in the effects of the pathogenic protein were observed between brain regions
(Jafar-Nejad et al., 2011), supports this idea.
In conclusion, our results show that the wild-type function of polyQ tracts is to mod-
ulate protein interactions depending on their molecular context. Therefore, the study of
polyQ proteins will require correlating modification of this context to modifications in
the protein interaction network.
5.7 Contributions
This chapter is a modified and extended version of Schaefer et al. (2012b). I did all the
computational analyses under supervision of Miguel Andrade. The interpretation of the
results was done together with Erich Wanker. The manuscript was written by Miguel
Andrade and me. For this thesis, I largely extended the sections associating polyQ with
PPIs after the publication of the manuscript.
76
6 Discussion
6.1 Selection of high-confidence and context-specific
interactions
Proteins do not act alone but achieve diverse cellular functions in cooperation with
other proteins. When these normal functions are interrupted, cells can end up in a
disease state. Therefore, the knowledge of the complex maps of PPIs and tools for the
interpretation of these data is fundamental for understanding of both normal cellular
function and processes that lead to disease. Accordingly, many research efforts focus on
the discovery of PPIs.
Accounting for the large number of diseases that is caused by perturbations of the
cellular PPI network, new research disciplines develop disease network models and pre-
dict disease causing proteins from PPI data (Barabási et al., 2011). In network-based
association studies genetic variation in a group of individuals carrying a disease is con-
trasted with knowledge on gene regulatory relations and physical interactions between
proteins to elucidate pathways affected by a disease (Califano et al., 2012). Network
pharmacology aims to identify novel drugs or drug targets based on analysis of PPI
data (Hopkins, 2008). Therapeutic strategies are developed that inhibit disease-specific
aberrant PPIs (Wells and McClendon, 2007; Zhao and Chmielewski, 2005). All of these
approaches depend on the knowledge of reliable and representative PPI maps.
Reaching these goals is difficult given that many methods for detecting PPIs produce
false positive measurements at large scales and fail to report many naturally occur-
ring interactions. Additionally, many interactions that have been measured are strongly
context-dependent and might occur only in a limited set of cell types or cellular compo-
nents. Lastly, technical limitations and research interests introduce strong biases on the
global interaction landscape reported so far.
In this thesis, we address these problems and present, at first, a method that assigns
a continuous confidence score to reported PPIs that reflects the amount and quality of
supporting experimental evidence. We believe that this is an essential contribution to
help the network biology community to cope with the rapidly growing amount of PPI
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data.
Though a few other approaches exist that integrate the experimental description for
the purpose of scoring PPIs, our approach focuses on experimental parameters only.
In comparison to the MINT score (Ceol et al., 2010), which is the closest to ours, we
computationally optimized the selection of parameters of the scoring formula. Also,
we developed a detailed quality assessment scheme that assigns an individual reliability
value to each of more than 100 experimental methods that report PPIs, unlike MINT
that weights experimental quality by how many interactions a method reports (high-
versus low-throughput). Another difference is that MINT weights the number of studies
by the number of times they have been cited. We believe that this further biases the
score distribution towards well studied protein pairs rather than identifying reliable
interactions. Together these differences might explain why our score outperforms the
MINT score when ranking interactions in terms of reproducibility.
Other approaches to score PPIs integrate functional information of the protein pair.
While we do see a correlation between the amount and quality of the experimental evi-
dence and the specificity of the functional similarity (Chapter 4), we choose to separate
these two concepts. Indeed, two proteins of the same pathway or transcriptions factors
of the same class are more likely to interact but there are important naturally occur-
ring interactions across functional classes. Accordingly, filtering a priori for functional
similarity will bias the resulting network further towards homogeneous interactions be-
tween proteins that are functionally well characterized. Instead, we suggest to apply
filters for experimental reliability and functional coherence independently, depending
on the research question. We showed in Chapter 4 how the generation of tissue- or
function-specific high-confidence networks can identify important causative interactions
in disease.
An analysis that takes into account network topology (for example, the identification
of hub proteins) or aims to estimate quality parameters of a novel screen using the over-
lap with existing PPI data (as suggested by Venkatesan et al. (2009)) depends on a
maximally unbiased network. In contrast, in Chapter 3 we described a large bias result-
ing from non-uniform bait usage in the PPI network and observed interactions among
well-studied proteins to have on average a higher confidence score. Accordingly, we see
a limitation of our scoring approach in the fact that any selection of high-scoring inter-
actions will further bias the resulting high-confidence network towards these frequently
studied proteins (applying functional scoring schemes instead will have the same effect).
In Chapter 5, we presented strategies to correct for the study bias and applied them
to the analysis of polyQ-containing proteins to show that they have more interaction
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partners than expected by chance. Indeed, correcting for the bias altered the outcome
significantly. In summary, the set of interactions for a network analysis needs to be
carefully chosen and requires one to choose the right balance between reliability and
functional coherence on one side and degree of bias on the other.
Using a large integrated network we studied the effect on the network topology of
merging thousands of studies. It is still under debate which distribution type would de-
scribe the degree distribution of PPI data best: the predominant view claims power-law
distribution of the PPI degree but usually bases this decision only on visual inspection
(Lima-Mendez and Van Helden, 2009). We find it interesting to note that for most exper-
imental PPI networks a power-law distribution cannot be fitted sufficiently well (Khanin
and Wit, 2006). For HIPPIE we observe a significant tendency (in the tail ≥ 45 interac-
tions) to be power-law distributed. This could be partially caused by the almost perfectly
power law distributed bait usage distribution in combination with the significant cor-
relation between bait usage and degree of a protein. In the end, maybe the process
of merging many networks introduces power law characteristics in integrated networks
rather than evolutionary processes such as gene duplication, which is commonly believed
to confer power-law properties to PPI networks (Bhan et al., 2002; Pastor-Satorras et al.,
2003).
Besides the challenge of dealing with uncertainty and biases in PPI networks, the
increasing amount of PPI data requires methods to identify interactions relevant to a
particular biological problem. For example, not all PPIs of a disease-related protein
contribute equally to disease development. Instead, a few alterations in the binding
patterns of certain proteins provide the basis of the disease phenotype. For example,
TP53 controls apoptosis upon DNA damage. Its activity is tightly controlled by different
pathways and in cancer cells these control mechanisms are often interrupted. An impor-
tant interaction that controls the activity of TP53 is with MDM2, which targets TP53
for degradation. Consequently, this interaction has been inhibited with small molecules
(Klein and Vassilev, 2004). In Chapter 4, we presented a strategy to highlight inter-
actions that might be relevant for disease mechanisms or in other non-disease contexts
by incorporating functional annotation and gene expression information in combination
with signal flow inferred from shortest paths connecting receptors with transcription
factors. To our knowledge we are the first to combine network algorithms and context
annotation to generate PPI networks of higher plausibility and to identify relevant in-
teractions within them. We validate our approach by demonstrating that our method
captures properties of canonical pathways, recovers known and novel disease mechanisms
and leads to networks of higher experimental reliability.
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Another way to use functional annotations in PPI networks is to correct for functional
biases in the protein set being studied. We exemplified this in Chapter 5 for the detection
of polyQ associated domains where we corrected for the bias towards transcription factors
among polyQ proteins.
To make the integrated, context-associated and scored network data available, we
implemented HIPPIE, a web tool that allows access to the constantly updated PPI
network and provides numerous analysis options to conduct the graph mining tasks
we have described here. Our approach of integrating PPI data with estimations of
experimental reliability, functional and expression information provides several different
views of the human PPI network:
• Disease networks can be studied under more realistic conditions by excluding PPIs
that would not occur in the affected cell type.
• Research is guided by highlighting interactions between proteins associated to the
research topic (e.g., between proteins involved in transcription or located in certain
cellular compartments).
• Analysis of networks can be restricted to small numbers of highly reliable interac-
tions.
The web tool HIPPIE combines many novel features that help experimentalists and
likewise computational network biologists in the evaluation and analysis of PPI networks.
6.2 PolyQ function and disease
We used our functionally annotated network to provide important insights into the bi-
ological role of polyQ, a research question that has been discussed for decades: already
more than 45 years ago structural features of glutamine-rich regions have been studied
(Krull et al., 1965) and in the 1990s Nobel prize winner Max Perutz published a series
of papers investigating the structure and function of polyQ (for example, (Perutz et al.,
1993)). Our observations, which provide evidence that polyQ stabilizes PPIs and suggest
that polyQ extends neighboring coiled-coil regions, are important contributions to the
understanding of polyQ function. Even though the main focus of our investigation of
polyQ function depends on network analyses, we observed that this cannot substantiate
our hypothesis alone and must be combined with other analyses on the genomic and
phylogenetic level. For example, observing more interaction partners indicates an in-
volvement in PPIs, but only the association to PPI domains on sequence level produces
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a consistent model explaining the mechanism by which polyQ stabilizes PPIs. Correlat-
ing polyQ presence at the genomic level with domains involved in aggregate clearance
finally revealed the constraints by which polyQ evolution is driven: as a PPI domain
its presence is beneficial but dangerous, since length expansion can drive the cell into
disease state. Only when a protection machinery is present can this risk be taken.
Our model provides answers to several questions that have been puzzling researchers
until now, like why transcription factors have more polyQ repeats than other proteins
(because they are involved in more PPIs) and why prokaryotes have almost no proteins
with polyQ repeats (because they do not have mechanisms to deal with aggregates
formed by polyQ repeat proteins).
Ataxin-1, like Huntingtin, is a polyQ disease protein. In a recent collaboration project
with Erich Wanker, we screened for modifiers of Ataxin-1 toxicity and observed a strong
enrichment of coiled-coils in the set of proteins enhancing the aggregation of Ataxin-1
with length expanded polyQ (Petrakis et al., 2012). Removing the coiled-coil from one
of these enhancing proteins, indeed reduced Ataxin-1 aggregation. In agreement with
another recent study (Fiumara et al., 2010), these observations implicate coiled-coils in
polyQ aggregation and thereby highlight the necessity of studying the wild type function
of polyQ proteins for the understanding of the polyQ disease mechanisms.
6.3 Outlook
The significance of pre- and post-translational modification mechanisms for the modu-
lation of the binding behaviour of a protein is becoming increasingly apparent: a recent
study observed an enrichment of protein binding motifs in protein sequences encoded
by alternatively spliced exons, which illustrates the importance of splicing for the mod-
ulation of PPIs (Weatheritt et al., 2012). Many protein interaction domains require
post-translational modifications (PTMs) of the targeted binding motif. For example,
the Src homology (SH2) domain binds phosphorylated tyrosine residues. Other PTMs
that facilitate interactions are ubiquitination and acetylation (an overview of PTM-
dependent PPIs is given in Seet et al. (2006)). Even though primary studies usually
report on characteristics of the tested protein and methods are developed to specifically
test for interactions conditional on PTMs (Wehr et al., 2008), PPI databases usually
do not consider PTMs or disease mutations of the interacting protein pair. Only a few
public databases report splice variants, mutations or PTMs in the proteins detected to
interact (often containing only a small number of entries). This is partly due to a lack
of standardization in the naming conventions for protein variants. As a start, UniProt
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developed a numbering system for different protein isoforms. A unified naming conven-
tion that allows one to characterize any deviation from a canonical protein sequence
would certainly help to build PPI resources that integrate information on protein vari-
ants and would, for example, allow studies on integrated datasets contrasting wild type
with disease networks.
To detect highly specific interactions that are only realized under limited number of
conditions and, hence, have never been measured, PPI experiments must be repeated
under varying biological conditions. Again, there is a lack of database infrastructure
to associate PPIs with these experimental conditions and so these experiments must be
accompanied by the development of resources that indicate the context under which a
PPI has been detected. We feel that the here presented tool HIPPIE is an important
contribution towards this goal.
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Table 1: Scores for experimental methods that detect PPIs.
Technique PSI Score
3 hybrid method MI:0588 5
acetylation assay 7.5
Affinity Capture-Luminescence 5
Affinity Capture-MS 5
Affinity Capture-RNA 2
Affinity Capture-Western 5
affinity chromatography technology MI:0004 5
affinity technology MI:0400 5
anti baitcoimmunoprecipitation MI:0006 5
anti tagcoimmunoprecipitation MI:0007 5
antibody array MI:0678 5
array technology MI:0008 3
atomic force microscopy MI:0872 9
beta galactosidase complementation MI:0010 5
beta lactamase complementation MI:0011 5
bimolecular fluorescence complementation MI:0809 6
Biochemical MI:0401 1
Biochemical Activity 5
bioluminescence resonance energy transfer MI:0012 6
Biophysical MI:0013 1
blue native page MI:0276 3
chromatin immunoprecipitation assay MI:0402 2
chromatography technology MI:0091 1
circular dichroism MI:0016 9
classical fluorescence spectroscopy MI:0017 7.5
Co-crystal Structure 10
Co-fractionation 1
Co-localization 1
coimmunoprecipitation MI:0019 5
colocalization by fluorescent probes cloning MI:0021 1
colocalization by immunostaining MI:0022 1
colocalization/visualisation technologies MI:0023 1
comigration in gel electrophoresis MI:0807 3
Continued on next page
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Table 1 – continued
Technique PSI Score
comigration in non denaturing gel electrophoresis MI:0404 3
comigration in sds page MI:0808 3
competition binding MI:0405 5
confocal microscopy MI:0663 1
copurification MI:0025 2
cosedimentation MI:0027 2
cosedimentation in solution MI:0028 2
cosedimentation through density gradient MI:0029 2
cross-linking study MI:0030 5
deacetylase assay MI:0406 7.5
demethylase assay MI:0870 7.5
dihydrofolatereductase reconstruction MI:0111 6
dynamic light scattering MI:0038 9
electron microscopy MI:0040 5
electron paramagnetic resonance MI:0042 9
electron tomography MI:0410 9
electrophoretic mobility shift assay MI:0413 2
electrophoretic mobility supershift assay MI:0412 2
enzymatic study MI:0415 1
enzyme linked immunosorbent assay MI:0411 5
experimental interaction detection MI:0045 1
far western blotting MI:0047 5
filamentous phage display MI:0048 6
filter binding MI:0049 5
fluorescence correlation spectroscopy MI:0052 10
fluorescence microscopy MI:0416 1
fluorescence polarization spectroscopy MI:0053 10
fluorescence technology MI:0051 1
fluorescence-activated cell sorting MI:0054 1
fluorescent resonance energy transfer MI:0055 6
footprinting MI:0417 3
FRET 6
gal4 vp16 complementation MI:0728 5
genetic interference MI:0254 0
gst pull down MI:0059 5
gtpase assay MI:0419 7.5
his pull down MI:0061 5
homogeneous time resolved fluorescence MI:0510 7
imaging technique MI:0428 1
in vitro MI:0492 1
in vivo MI:0493 1
Continued on next page
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Table 1 – continued
Technique PSI Score
in-gel kinase assay MI:0423 7.5
inferred by curator MI:0364 1
ion exchange chromatography MI:0226 3
isothermal titration calorimetry MI:0065 10
kinase homogeneous time resolved fluorescence MI:0420 7.5
lambda phage display MI:0066 6
lex-a dimerization assay MI:0369 5
light microscopy MI:0426 1
light scattering MI:0067 10
mammalian protein protein interaction trap MI:0231 6
mass spectrometry studies of complexes MI:0069 5
methyltransferase assay MI:0515 7.5
methyltransferase radiometric assay MI:0516 7.5
molecular sieving MI:0071 2
no experiment assigned 0
nuclear magnetic resonance MI:0077 10
peptide array MI:0081 5
phage display MI:0084 6
phosphatase assay MI:0434 7.5
phosphotransfer assay 7.5
polymerization MI:0953 5
protease assay MI:0435 7.5
protein array MI:0089 5
protein complementation assay MI:0090 5
protein cross-linking with a bifunctional reagent MI:0031 5
protein kinase assay MI:0424 7.5
protein tri hybrid MI:0437 5
Protein-peptide 5
Protein-RNA 0
pull down MI:0096 2.5
pull-down/mass spectrometry 5
Reconstituted Complex 10
reverse phase chromatography MI:0227 1
reverse two hybrid MI:0726 5
ribonuclease assay MI:0920 7.5
saturation binding MI:0440 7.5
scintillation proximity assay MI:0099 7.5
solid phase assay MI:0892 1
surface plasmon resonance MI:0107 10
t7 phage display MI:0108 6
tandem affinity purification MI:0676 5
Continued on next page
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Table 1 – continued
Technique PSI Score
tox-r dimerization assay MI:0370 5
transcriptional complementation assay MI:0232 5
transmission electron microscopy MI:0020 5
two hybrid fragment pooling approach MI:0399 5
Two-hybrid MI:0018 5
ubiquitin reconstruction MI:0112 5
x ray scattering MI:0826 9
x-ray crystallography MI:0114 10
x-ray fiber diffraction MI:0825 9
yeast display MI:0115 5
Table 2: Comprehensive network of influenza interference with cytokines. The
directed networks were generated by computing shortest paths between viral proteins
and genes upregulated upon influenza infection. Only viral proteins and host factors
up to layer two are shown. Layer two proteins were required to be associated with
cytokine-related pathways.
Viral proteins First layer Second layer Tissues
PB1, PB2 BHLHE40 STAT3 Lung
PA CDC42EP4 CDC42 Lung
PB2 CREB3 TAP1 Lung
NP MAGED1 PJA1 Lung
NP MAGED1 IRAK1 Lung
NP MAGED1 HSPB1 Lung
NP MAGED1 TOLLIP Lung
PB1, PB2, M2 RBPMS EWSR1 Lung
PB1, PB2, M2 RBPMS TOLLIP Lung
PA RNF5 UBE2D2 Lung
PA RNF5 UBE2D4 Lung
PA RNF5 PXN Lung
PA RNF5 UBE2V1 Lung
PA RNF5 UBE2Z Lung
PA RNF5 UBE2E3 Lung
PB1 SIAH1 STAT3 Lung
PB1 SIAH1 MYD88 Lung
PB1 SIAH1 UBE2E3 Lung
PB1 SIAH1 UBE2D2 Lung
PB1 TRIP6 SRC Lung
PB1 TRIP6 NEDD9 Lung
Continued on next page
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Table 2 – continued
Viral proteins First layer Second layer Tissues
NS2 AIMP2 STUB1 Lung, BET
PB1, PB2 BHLHE40 TOLLIP Lung, BET
PB2 CREB3 JUN Lung, BET
PB2 CREB3 BCL2L1 Lung, BET
NS1, M1 PRKRA SHC1 Lung, BET
NS1, M1 STAU1 CDC42 Lung, BET
NS1, M1 STAU1 RAC1 Lung, BET
PB1 TRIP6 PXN Lung, BET
NS2 AIMP2 PPP2R1A BET
PB1, PB2 BHLHE40 SUMO1 BET
PA NDUFS3 MYC BET
NS1, M1 PRKRA RB1 BET
NS1, M1 STAU1 RPS6 BET
NS1, M1 STAU1 RPL6 BET
NS1, M1 STAU1 HDAC1 BET
NS1, M1 STAU1 UBE2D3 BET
NS1, M1 STAU1 FLNB BET
PB1 TRIP6 PTK2 BET
PB1 TRIP6 FLNB BET
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Nomenclature
AD Activation domain
BD DNA-binding domain
GO Gene Ontology
HD Huntington’s disease
MS Mass spectrometry
PI Phosphatidylinositol
PolyP Polyproline
PolyQ Polyglutamine
PPI Protein-protein interaction
PSI-MI Proteomics Standards Initiative Molecular Interaction
PSICQUIC Proteomics Standards Initiative Common Query Interface
PTM Post-translational modification
SILAC Stable isotope labeling by amino acids in cell culture
TAP Tandem affinity purification
UTR Untranslated regions
Y2H Yeast two-hybrid
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